Advertisement

A

  • F. von Bruchhausen
  • S. Ebel
  • A. W. Frahm
  • E. Hackenthal
  • Margitta Albinus
  • Hassan-Fahmy Ali
  • Syed Laik Ali
  • Gudrun Amschler
  • Uwe Amschler
  • Erwin von Angerer
  • Peter Barth
  • Wolfgang Barthel
  • Kurt Bauer
  • Andrea Bauer
  • Jürgen Beckmann
  • Winfried Beil
  • Jürgen Beitz
  • Günther Bellmann
  • Thorsten Beyrich
  • Franz Bossle
  • Helmut Bräunlich
  • Matthias Bräutigam
  • Kerstin Brinkmann
  • Adalbert Brinz
  • Franz von Bruchhausen
  • Kay Brune
  • Axel Büge
  • Ulrich Bürger
  • Wolfram Christ
  • Klaus Daneck
  • Gerd Dannhardt
  • Helga Doering
  • Siegfried Ebel
  • Kurt Eger
  • Peter Emig
  • Thomas Erker
  • Bernhard Feil
  • Monika Fett
  • August Wilhelm Frahm
  • Margarete Frahm
  • Klaus-Jürgen Freundt
  • Wolfram Gaida
  • Detlef Geffken
  • Ulrich Geis
  • Klaus Geldsetzer
  • Ulrich Gessner
  • Erika Glusa
  • Berthold Göber
  • Margarete Goppelt-Strübe
  • Wilhelm Gössling
  • Eberhard Gottwald
  • Beate Grates
  • Annette Graul
  • Sibylle Greiner
  • Adolf Grisk
  • Michael Grosam
  • Jan Gustafsson
  • Hartmut Gustmann
  • Jürgen Haas
  • Axel Haberkorn
  • Eberhard Hackenthal
  • Annette Häfner
  • Boris Haluszczynski
  • Achim Harder
  • Susanne Hartmann
  • Heribert Häusler
  • Marcus Heidenreich
  • Gerhard Heinemeyer
  • Bernd Hempel
  • Monika Herboth
  • Klaus Herbrand
  • Sibylle Hoedt-Schmidt
  • Wolfgang Hoefke
  • Hermann Hoffmann
  • Ute Hoffmann-Schollmayer
  • Bernhard Hofmann
  • Ulrike Holzgrabe
  • Anette Hornberger
  • Ute Hübner-Steiner
  • Martin Hug
  • Wolfgang Ibrom
  • Walter Janßen
  • Angela Jördens
  • Ilmar Jurna
  • Günther Kaiser
  • Dieter-Abbo Kalbhen
  • Petra Kisser
  • Christoph Klett
  • Stephanie Klett
  • Gerd Kobal
  • Johannes Koehler
  • Axel Kramer
  • Birgit Krammer
  • Gottfried Kreutz
  • Reinhard Kroker
  • Markus Kuhn
  • Norbert Kühn
  • Dorothea Landsiedel
  • Andreas Langner
  • Martina Laudszun
  • Jochen Lehmann
  • Marion Sylvia Lehner
  • Stefan Leiner
  • Hans Löwe
  • Johannes Mann
  • Detlef Manns
  • Wolfgang Matthiessen
  • Rainer Maue
  • Peter Maul
  • Andreas Maurer
  • Ralf Mayer
  • Wolfgang Meindl
  • Werner Meise
  • Klaus Menges
  • Paul Messinger
  • Hans-Jürgen Mest
  • Frank Peter Meyer
  • J. Mollière
  • Rudolf Morgenstern
  • Wolfgang Morick
  • Joachim Mössner
  • Alfred Müller
  • Walter E. Müller
  • Klaus Müller
  • Christa Müller
  • Daniel Müller
  • Michael Neugebauer
  • Ottmar Neugebauer
  • Peter Nickel
  • Peter Nuhn
  • Bernd Nürnberg
  • Joachim Oertel
  • Michael Oettel
  • Tilmann Ott
  • Thomas Otzen
  • Hartmut Oßwald
  • Peter Pachaly
  • Helmut Pelzer
  • Karl-Uwe Petersen
  • Siegfried Pfeifer
  • Klaus Pietrzik
  • Kathrin Pöllath
  • Olaf Queckenberg
  • Bernd Raffelsberger
  • Eberhard Reimann
  • Jörg Remien
  • Markus Reuß
  • Andreas Reymann
  • Joachim Richter
  • Peter H. Richter
  • Hubert Richter
  • Klaus Rittinghaus
  • Hans Rommelspacher
  • Gerhard Rücker
  • Gerhard Schaefer
  • Klaus Schaefer
  • Jutta Schcerer
  • Helmut Schlager
  • Hildegard Schleinitz
  • Wolfgang Schlichter
  • Gerhard Schmidt
  • Wolfgang Schmutzler
  • Johannes Schräder
  • Thomas Schulz-Schalge
  • Harald Schütz
  • Helmut Schwilden
  • Gisela Skopp
  • Ulrich Speck
  • Marcus Spohn
  • Ralf Stahlmann
  • Johannes-Peter Stasch
  • E. Staubli
  • Jürgen Steinmeyer
  • Karl-Heinz Stiefvater
  • Michael Streek
  • Günther Strippel
  • Karl-Heinz Surborg
  • Ulf Sürig
  • Istvan Szelenyi
  • Alfred Thomas
  • Herbert Trampisch
  • Reinhard Troschütz
  • Bernard Unterhalt
  • Eugen J. Verspohl
  • Sabine Vogel
  • Franz-Josef Volk
  • Sven Völkl
  • Heinz Walther
  • Horst Weber
  • Martin Wenzel
  • Marion Weyandt-Spangenberg
  • Sandra Wich
  • Burkhard Wichert
  • Hilke Winterhoff
  • Peter Witte
  • Monika Wolff

References

  1. 1.
    Junge B et al. (1984) Carbohydrat Res 128:235–268CrossRefGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Schmidt DD, Schäfer D et al. (1977) Naturwissenschaften 64:535–536PubMedCrossRefGoogle Scholar
  4. 4.
    Ogawa S, Shiabata Y (1988) Chem Commun 605–606Google Scholar
  5. 5.
    Bayer, Glucobay -Standardinformation für KrankenhausapothekerGoogle Scholar
  6. 6.
    Boch K, Pedersen H (1984) Carbohydrat Res 132:142– 149CrossRefGoogle Scholar

References

  1. 1.
    Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P (1979) Res Exp Med 175:81–86CrossRefGoogle Scholar
  2. 2.
    Dimitriadis G, Tessari P, Go V (1982) Effects of acar-bose on metabolic and hormonal responses to meal ingestion and intravenous glucose in normal man. In: Creutzfeldt W (Hrsg.) First International Symposium on Acarbose, Amsterdam, Excerpta Medica, S.216– 222Google Scholar
  3. 3.
    Radziuk J, Kemmer F, Berchtold P, Vranic M (1982) Quantitation of the effects of the α-glucosidase inhibitor acarbose on the hydrolysis and absorption of sucrose and hormone responses in man. In: Creutzfeldt W (Hrsg.) First International Symposium on Acarbose, Amsterdam, Excerpta Medica, S. 113–122Google Scholar
  4. 4.
    Sjöström L, William-Olsson T (1981) Curr Ther Res 30:351–366Google Scholar
  5. 5.
    Caspary WF (1978) Lancet I:1.231–1.233Google Scholar
  6. 6.
    Aubell R, Boehme K, Berchthold P (1983) Arzneim Forsch 33:1.314–1.318Google Scholar
  7. 7.
    Müller FO (1986) Acta Pharmacol Toxicol, Suppl. VGoogle Scholar
  8. 8.
    Pütter J (1980) Studies on the pharmacokinetics of acarbose in humans. In: Brodbeck U (Hrsg.) Enzyme inhibitors, Verlag Chemie, Weinheim, S. 139–151Google Scholar
  9. 9.
    Raptis S, Dimitriadis G, Karaiskos C et al (1982) Short-and long-term studies of acarbose on various metabolic parameters and insulin requirements assessed by the artificial endocrine pancreas. In: Creutzfeldt W (Hrsg.) First International Symposium on Acarbose, Amsterdam, Excerpta Medica, S. 393Google Scholar
  10. 10.
    Sachse G, Mäser E, Laube H et al (1982) Effect on long-term acarbose therapy on the metabolic situation of sulphonylurea-treated diabetics. In: Creutzfeldt W (Hrsg.) First International Symposium on Acarbose, Amsterdam, Excerpta Medica, S.298Google Scholar

VE

  1. 1.
    Fierz-David HE, Kuster W (1939) Helv Chim Acta 22:82CrossRefGoogle Scholar
  2. 2.
    Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, 2. Aufl., Bd. I, Noyes Publications, Park Ridge ,S. 5Google Scholar
  3. 3.
    Basil B, Clark Jr., Coffee ECJ, Jordan R, Loveless AH, Pain DL, Wooldridge KRH (1976) J Chem Med 19:399CrossRefGoogle Scholar

References

  1. 1.
    Singh BN, Thoden WR, Ward A (1985) Drugs 29:531– 569PubMedCrossRefGoogle Scholar
  2. 2.
    Abrahamsson T (1989) Eur J Pharmacol 164:121–128PubMedCrossRefGoogle Scholar
  3. 3.
    Pong SF, Tinkham CL (1983) J Pharm Pharmacol 35:198–199PubMedCrossRefGoogle Scholar
  4. 4.
    De Bono G, Kaye CM, Roland E, Summers AJH (1985) Am Heart J 109:1.211–1.224Google Scholar
  5. 5.
    van den Meiracker AH, Man in’t Veld AJ, Boomsma F, Fischberg DJ, Molinoff PB, Schalekamp MA (1989) Circulation 80:903–914PubMedCrossRefGoogle Scholar
  6. 6.
    Mar 29, S. 781–782Google Scholar
  7. 7.
    Basso A, Piantanelli L, Cognini G, Giunta S, Andreoni A, Paciaroni E (1985) Pharmacology 31:278–283PubMedCrossRefGoogle Scholar

References

  1. 1.
    Carpy A, Gadret M, Hickel D, Leger JM (1979) Act CrystB35:185Google Scholar
  2. 2.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar

References

  1. 1.
    Osakeyhtio Star AB (1985) Neth. Appl. NL 8402, 084, zit. nach CA (1985) 102:220570aGoogle Scholar
  2. 2.
    Nelson WL, Powell ML, Wennerstrom JE (1978) J Org Chem 43:4907CrossRefGoogle Scholar
  3. 3.
    Reeves RE (1951) Adv Carbohydr Chem 6:107PubMedCrossRefGoogle Scholar

References

  1. 1.
    Osakeyhtio Star AB (1985) Neth App NL 8402, 084, zit. nach CA (1985) 102:220570aGoogle Scholar
  2. 2.
    Nelson WL, Powell ML, Wennerstrom JE (1978) J Org Chem 43:4.907Google Scholar
  3. 3.
    Reeves RE (1951) Adv Carbohydr Chem 6:107PubMedCrossRefGoogle Scholar

References

  1. 1.
    Schmidt G (1979) Acecarbromal. In: Graf E, Preuß Fr R (Hrsg.) Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte, Vanden-hoek und Ruprecht, Göttingen Bd I/2, S. 1Google Scholar
  2. 2.
    Matta G, Lopes ES (1964) Rev Port Farm 14:336–345Google Scholar
  3. 3.
    Look JM (1967) J Ass Off Anal Chem 50:664–666Google Scholar
  4. 4.
    Dibbern H-W (1963) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor AulendorfGoogle Scholar
  5. 5.
    D. R. P. 327129 ref in Beilstein E II 3,52Google Scholar
  6. 6.
    Hofmann H, Mehler A, Deeken U (1965) Dtsch Apoth Ztg 105:139–141Google Scholar
  7. 7.
    Paulus W, Goenechea S, Buttler R (1969) Arzneim Forsch 19:388–390Google Scholar
  8. 8.
    Thielemann H (1975) Sci Pharm 43:91–100Google Scholar
  9. 9.
    Brandenburger H (1970) Pharm Acta Helv 45:394–413Google Scholar

EK

  1. 1.
    Covington TR, DiPalma Jr., Hussar DA, Lasagna L, Tatro DS, Whitsett TL (1988) Acecarbromal. In: Ka-strup EK, Olin BR, Connel SI (Eds.) Drug facts and comparisons, Lippincott, St. Louis, S. 1090Google Scholar
  2. 2.
    Käferstein H, Sticht G (1974) Arzneim Forsch 24:1619–1621Google Scholar
  3. 3.
    Weber E (1988) Taschenbuch der unerwünschten Arzneiwirkungen, Fischer, Stuttgart, S. 691–693Google Scholar
  4. 4.
    Desphande AV (1979) Niger J Pharmacol 10:80–82Google Scholar
  5. 5.
    Wellhöner HH (1990) Allgemeine und systematische Pharmakologie und Toxikologie, 5. Aufl., Springer, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona, S. 353CrossRefGoogle Scholar

Hg

  1. 1.
    Sternbach LH, Kaiser S (1952) J Am Chem Soc 74:2.215–2.218Google Scholar
  2. 2.
    Bodor N, Kaminski JJ (1980) J Med Chem 23:566–569PubMedCrossRefGoogle Scholar
  3. 3.
    Lambrecht G (1976) Arch Pharm 309:235–239CrossRefGoogle Scholar
  4. 4.
    Arzamastzev AP, Kofman MD, Yaskina DZ, Lirova MP (1975) Sb Nauchn Tr -Tsentr Aptechn Nauchno -Issled Inst 13:200–205, CA (1976) 85:198.089gGoogle Scholar
  5. 5.
    Kuznetsov VI, Volkova NS (1967) Khim Farm Zh 1:41, CA (1967) 66:94.031uGoogle Scholar
  6. 6.
    Baik SI, Akopyan OA, Kazmirchuk LV (1983) Farmat-siya 32:65–66, Ca (1983) 99:10.937uGoogle Scholar
  7. 7.
    Belikov VG, Lukyanchikova GI, Blinova TI (1986) Farmatsiya 35:13–16, CA (1986) 104:213.356yGoogle Scholar
  8. 8.
    Lukyanchikova GI, Tirapolskaya SG, Lukashova LA, Blinova TI (1986) Farmatsiya 35:54–57, CA (1986) 104:174.489xGoogle Scholar
  9. 9.
    Kovalchuk TV, Medvedovskii AA, Rinker KM, Ar-zyaeva OA (1985) Farm Zh:77–78, CA (1986) 104:75.142xGoogle Scholar
  10. 10.
    Nagovitsina LV, Sichko AI, (1988) SU 1.377.688, CA (1988) 109:85.483bGoogle Scholar

References

  1. 1.
    Mashkovsky MD, Yakahontov LN (1969) Prog Drug Res 13:293–339PubMedGoogle Scholar
  2. 2.
    Cho AK, Jenden DJ, Lamb SI (1972) J Med Chem 15:391–394PubMedCrossRefGoogle Scholar
  3. 3.
    Martin-Smith M, Smail GA, Stenlake JB (1967) J Pharm Pharmac 19:561–589CrossRefGoogle Scholar
  4. 4.
    Ringdahl B, Ehler FJ, Jenden DJ (1982) Mol Pharmacol 21:594–599PubMedGoogle Scholar
  5. 5.
    Bastide P, Tronche P, Roucher F (1968) Arzneim Forsch 18:322–324Google Scholar
  6. 6.
    Chiang TS, Leaders FE (1971) Arch int Pharmacodyn 189:295–302PubMedGoogle Scholar
  7. 7.
    Mashkosvky DM, Zaitseva CA (1968) Arzneim Forsch 18:320–322Google Scholar

GA

  1. 1.
    Bezou LM (1977) DE 2640209, zit. nach CA (1977) 87:23088vGoogle Scholar
  2. 2.
    Lambrecht G (1976) Arch Pharm 309:235–239CrossRefGoogle Scholar
  3. 3.
    Kuhnert-Brandstätter M, Bösch L, Eckstein G (1978) Sci Pharm 46:180–188Google Scholar
  4. 4.
    Lambrecht G (1976) Eur J Med Chem -Chim Ther 11:461–466Google Scholar
  5. 5.
    Yalcindag ON, Onur E (1970) Bull Soc Pharm Bordeaux 109:73–78Google Scholar

gs

  1. 1.
    Shumilo TV, Vaisman GA (1971) Farm Zh 26:74–75, zit. nach CA (1971) 74:103071fPubMedGoogle Scholar
  2. 2.
    Solomonova SG (1970) Khim Issled Farm:132–133, zit. nach CA (1972) 76:49997pGoogle Scholar

References

  1. 1.
    Boltze KH et al (Troponwerke Dinklage und Co). Fr 2,192,828; Ger Offen 2,234,651Google Scholar
  2. 2.
    Drugs of the future (1977) 2:423–425Google Scholar
  3. 3.
    Yoneda M et al (1981) Yakugaku Zarski 101:939–944, zit. nach CA 96:40817kGoogle Scholar

sT

  1. 1.
    Classen HG, Schramen V (1980) Arzneim Forsch 30:1.313–1.468Google Scholar
  2. 2.
    Jacobi H, Janda B, Schröder J, Pelester B, Hostmann H(1983) Med Welt 34:1.277–1.281Google Scholar
  3. 3.
    Köhler G, Dell HD, Kamp R (1981) Z Rheumatol 40:97–99PubMedGoogle Scholar
  4. 4.
    Köhler G (1982) Fortschr Med 100:1.723–1.727Google Scholar
  5. 5.
    Seissiger L, Dell HD (1987) Z Rheumatol 46 (Suppl.l): 65–69PubMedGoogle Scholar
  6. 6.
    Wietfeld K, Rübsamen B, Rechziegler H, Bernard I (1986) Med Welt 37:1.073–1.076Google Scholar
  7. 7.
    Thebud-Lassak R, Dullenkopf B, Rechziegler H (1989) Rheuma 9:80–92Google Scholar
  8. 8.
    Brackertz D, Müller W (1982) Therapiewoche 32:2.493–2.498Google Scholar
  9. 9.
    Bernard I, Zündorf P, Rechziegler H (1987) Der Kassenarzt 27:34–38Google Scholar
  10. 10.
    Dörfler H (1985) Therapiewoche 35:1.161–1.166Google Scholar

Sm/KA

  1. 1.
    Herzfeldt CD (1980) Pharm Ztg 125:613Google Scholar

VF

  1. 1.
    Montigel C, Pulver R (1955) Schweiz med Wschr 85:586–590PubMedGoogle Scholar
  2. 2.
    Matschiner JT, Bell RG, Amelotti JM, Knauer TE (1970) Biochim biophys Acta 201:309–315PubMedCrossRefGoogle Scholar
  3. 3.
    Bell RG, Matschiner JT (1972) Nature 237:32–33PubMedCrossRefGoogle Scholar
  4. 4.
    Larson AE, Suttie JW (1978) Proc Natl Acad Sci 75:5413–5416PubMedCrossRefGoogle Scholar
  5. 5.
    Olson RE (1984) Annu Rev nutr 4:281–337PubMedCrossRefGoogle Scholar
  6. 6.
    Park BK, Scott AK, Wilson AC, Haynes BP, Brecken-ridge AM (1984) Br J Clin Pharmac 18:655–662CrossRefGoogle Scholar
  7. 7.
    Friedman PA (1984) N Engl J Med 310:1458–1460PubMedCrossRefGoogle Scholar
  8. 8.
    Hauschka PV (1979) Osteacalcin in developing bone systems. In: Suttie JW (Hrsg.) Vitamin K metabolism and vitamin K-dependent proteins, University Park Press, Baltimore, S. 227 ff.Google Scholar
  9. 9.
    Price PA, Epstein DJ, Lothringer JW, Nishimoto SK, Poser JW, Williamson MK (1979) Structure and function of the vitamin K-dependent protein of bone. In: Suttie JW (Hrsg.) Vitamin K metabolism and vitamin K-dependent proteins, University Park Press, Baltimore, S. 219 ff.Google Scholar
  10. 10.
    Dieterle W, Faigle JW, Montigel C, Sulc M, Theobald W (1977) Europ J Clin Pharmacol 11:367–375CrossRefGoogle Scholar
  11. 11.
    Godbillon J, Richard J, Gérardin A, Meinertz T, Kasper W, Jaehnchen E (1981) Brit J Clin Pharmacol 12:621–629CrossRefGoogle Scholar
  12. 12.
    Fitos I, Visy J, Magyar A, Kajtár J, Simonyi M (1989) 1-acid glycoprotein Biochem Pharmacol 38:2259–2262CrossRefGoogle Scholar
  13. 13.
    Meinertz T, Kasper W, Kahl C, Jaehnchen E (1978) Brit J Clin Pharmacol 5:187–188CrossRefGoogle Scholar
  14. 14.
    LeRoux Y, Richard J (1977) J Pharm Sci 66:997– 1000CrossRefGoogle Scholar
  15. 15.
    Jaehnchen E, Meinertz T, Gilfrich HJ, Kersting F, Groth U (1978) Br J Clin Pharmac 5:437–440CrossRefGoogle Scholar
  16. 16.
    Hull R,HirshJ (1983) Arch Intern Med 143:2061–2063PubMedCrossRefGoogle Scholar
  17. 17.
    Jaenecke J (1982) Antikoagulantien-und Fibrinolyse-therapie, Georg Thieme Verlag, Stuttgart New YorkGoogle Scholar
  18. 18.
    Steiner RA, Keller K, Lüscher T, Schreiner WE (1989) Arch Gynecol Obstetr 244:141–150CrossRefGoogle Scholar
  19. 19.
    Frick P (1979) Schweiz Med Wschr 109:334–336PubMedGoogle Scholar
  20. 20.
    Ritter B (1982) Antikoagulantien beim akuten Myo-kardinfarkt und in der Rekonvalenszenzphase. In: Roskamm H, Reindell H (Hrsg.) Herzkrankheiten, Springer Verlag, Berlin Heidelberg New York, S.977– 978Google Scholar
  21. 21.
    Loeliger EA, Hensen A, Kress F, van Dijk L, Fekkes N, Hemker H (1967) Acta Med Scand 182:549–566PubMedCrossRefGoogle Scholar
  22. 22.
    Smith P, Arnesen H, Holme I (1990) N Engl J Med 323:147–152PubMedCrossRefGoogle Scholar
  23. 23.
    Loeliger EA, Lewis SM (1982) Lancet 1:318–320CrossRefGoogle Scholar
  24. 24.
    Kirkwood TBL (1983) Thrombos Haemostas 49:238– 244Google Scholar
  25. 25.
    Loeliger EA, van den Besselaar AMHP, Lewis SM (1985) Thrombos Haemostas 53:148–154Google Scholar
  26. 26.
    Drug Information of the Health Care Provider: USP DI™ Vol. 1 (1984) Anticoagulants (Systemic), S. 117ff.Google Scholar
  27. 27.
    Loeliger EA (1980) Drugs affecting blood clotting, fibrinolysis and haemostasis. In: Dukes MNG (Hrsg.) Meyler’s side effects of drugs, Excerpta medica, Amsterdam Oxford Princeton, S. 587–613Google Scholar
  28. 28.
    Palacios-Macedo X, Diaz-Devis C, Escudero J (1969) Amer J Cardiol 24:853–856PubMedCrossRefGoogle Scholar
  29. 29.
    Levine MN, Raskob G, Hirsh J (1985) Drugs 30:444– 460PubMedCrossRefGoogle Scholar
  30. 30.
    Lechner K, Korninger C, Kyrle P, Geissler K, Niessner H, Pabinger I, Panzer S, Gössinger H, Bettelheim P, Hinterberger W (1987) Wiener klin Wschr 99:203–210Google Scholar
  31. 31.
    Loeliger EA (1985) Amer. Heart J. 110:1322–1323PubMedCrossRefGoogle Scholar
  32. 32.
    Teepe RG, Broekmans AW,Vermeer BJH, Nienhuis AM, Loeliger EA (1986) Arch Dermatol 122:1408– 1412PubMedCrossRefGoogle Scholar
  33. 33.
    van Amstel WJ, Boekhout-Mussert MJ, Loelinger EA (1978) Blut 36:89–93PubMedCrossRefGoogle Scholar

sw

  1. 1.
    Clarke EGC (Hrsg.) (1969) Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar

Eb/kb

  1. 1.
    Fielding S, Lal H (1978) Behavioral actions of neuroleptics. In: Iversen LL, Iversen SD, Snyder SH (Hrsg.) Handbook of psychopharmacology, Vol.10, Plenum Press, New York, S. 91–128CrossRefGoogle Scholar
  2. 2.
    Estler CJ (1983) Lehrbuch der allgemeinen und systematischen Pharmakologie und Toxikologie, Schattauer, Stuttgart New YorkGoogle Scholar
  3. 3.
    Reichlin S, Boyd AE (1978) Psychoneuroendocrino-logy 3:113–130CrossRefGoogle Scholar
  4. 4.
    Gordon M (1967/1974) Psychopharmacological agents, Vols. II and III, Academic Press, New YorkGoogle Scholar
  5. 5.
    Klein DF, Gittelman R, Quitkin F, Rifkin A (1980) Diagnosis and drug treatment of psychiatric disorders: adults and children, 2nd ed., Williams & Wilkins, BaltimoreGoogle Scholar
  6. 6.
    Creese I, Burt D, Snyder SH (1978) Biochemical actions of neuroleptic drugs: focus on dopamine receptor. In: Iversen LL, Iversen SD, Snyder SH (Hrsg.) Handbook of psychopharmacology, Vol. 10, Plenum Press, New York, S. 37–89CrossRefGoogle Scholar
  7. 7.
    Snyder SH, Yamamura H (1977) Arch Gen Psychiatry 34:236–239PubMedCrossRefGoogle Scholar
  8. 8.
    Leysen JE (1982) Review on neuroleptic receptors: specificity and multiplicity of in vitro binding relates to pharmacological activity. In: Usdin E, Dahl S, Gram LF, Lingjaerde O (Hrsg.) Clinical pharmacology in psychiatry: neuroleptic and anti-depressant research, Macmillan, Basingstoke, Hants., UK, S. 35Google Scholar
  9. 9.
    Hall LW, Clarke KW (1983) Veterinary Anaesthesia, 8th ed., Bailliere Tindall, LondonGoogle Scholar
  10. 10.
    Lang SM, Eglen RM, Henry AC (1979) Vet Record 27:397–398CrossRefGoogle Scholar
  11. 11.
    Ballard S, Shults T, Kownacki AA, Blake JW, Tobin T (1982) J Vet Pharmacol Therap 5:21–31CrossRefGoogle Scholar
  12. 12.
    Seeman P (1972) Pharmacol Rev 24:583–655PubMedGoogle Scholar
  13. 13.
    Yen CY, Stanger RL, Millmann N (1959) Arch Int Pharmacodyn Ther 123:179–185PubMedGoogle Scholar
  14. 14.
    Booth NH (1982) Psychotropic agents/Azepromazine maleate. In: Booth NH, McDonald LE (Hrsg.) Veterinary pharmacology and therapeutics, 5th ed., The Iowa State University Press/AMES, S. 329–332Google Scholar
  15. 15.
    Guyton CL, Missaghi E, Marshall PM (1976) Am J Vet Rec 37:1287–1289Google Scholar
  16. 16.
    Farver TB, Haskins SC, Patz JD (1986) Am J Vet Res 47/3:631–635Google Scholar
  17. 17.
    Garland JE, White KB (1968) zit. in14Google Scholar
  18. 18.
    Steffey EP, Kelly AB, Farver TB, Woliner MJ (1985) J Vet Pharmacol Therap 8:290–302CrossRefGoogle Scholar
  19. 19.
    Parry BW, Anderson GA, Gay CC (1982) Austr Vet J 59:148–151CrossRefGoogle Scholar
  20. 20.
    Parry BW, Anderson GA (1983) J Vet Pharmacol Therap 6:121–126CrossRefGoogle Scholar
  21. 21.
    Hafez M, Hamed MS, Hasan SA, El-Shafie M, Abo Egle MH (1984) J Egypt Med Assoc 67:313–325Google Scholar
  22. 22.
    Walker BE, Patterson A (1974) Teratology 10:159–164PubMedCrossRefGoogle Scholar
  23. 23.
    Pugh DM (1964) Vet Rec 76:439–442Google Scholar
  24. 24.
    Mutschier E (1975) Die Psyche beeinflussende Phar-maka (Psychopharmaka)/Vergiftungen. In: Mutschler E (Hrsg.) Arzneimittelwirkungen, 3.Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S.522Google Scholar

rk

  1. 1.
    Schmitt J, Hallot A, Comoy P, Suquet M, Fallard R, Boitard J (1957) Bull Soc Chim France: 1474–1481Google Scholar

KU

  1. l. Schmitt J, Hallot A, Comoy P, Suquet M, Fallard R, Boitard J (1957) Bull Soc Chim France: 1.474–1.481Google Scholar
  2. 2.
    El-Shabouri SR, Taha AM, Hussin SA (1982) Pharmazie 37:71–72Google Scholar
  3. 3.
    Cailleux A, Turcant A, Premel-Cabic A, Allain P (1981) J Chromatogr Sci 19(4):163–176PubMedCrossRefGoogle Scholar
  4. 4.
    Maurer H, Pfleger K (1984) J Chromatogr 306:125–145PubMedGoogle Scholar
  5. 5.
    Kabasakalian P, McGlotten J (1959) Anal Chem 31:431–433CrossRefGoogle Scholar
  6. 6.
    Laurent A, Bourdon R (1975) Ann Pharm Fr 33:171–181PubMedGoogle Scholar

KU

  1. 1.
    Clauß K, Jensen H (1973) Angew Chem 85:965–973CrossRefGoogle Scholar
  2. 2.
    Linkies A, Reuschling DB (1990) Synthesis 405–406Google Scholar

Ub

  1. 1.
    Clauß K, Jensen H (1973) Angew Chem 85:965–973CrossRefGoogle Scholar
  2. 2.
    Linkies A, Reuschling DB (1990) Synthesis 405–406Google Scholar

Ub/wi

  1. 1.
    Streuli CA (1958) Anal Chem 30: 997CrossRefGoogle Scholar
  2. 2.
    Kertesz P, Förhecz K (1972) Fresenius Z Anal Chem 258:288CrossRefGoogle Scholar

Eb

  1. 1.
    BAz, Nr. 109a vom 16.06.1987Google Scholar

vB

  1. 1.
    Maren TH, Mayer E, Wadsworth BC (1954a) Bull John Hopk Hosp 95:1199–243Google Scholar
  2. 2.
    Maren TH, Robinson B (1960) Bull John Hopk Hosp 106:1–24Google Scholar
  3. 3.
    Maren TH (1969) Physiol Rev 47:595–781Google Scholar
  4. 4.
    Maren TH (1969) Renal carbonic anhydrase and sulfonamide inhibitors. In: Eichler O, Farah A, Herken H, Welch AD (Hrsg.) Diuretica Handb Exp Pharmacol, Springer, Berlin Heidelberg New York, 24:193–256Google Scholar
  5. 5.
    Maren TH, Parcell AL, Malik MN (1960) J Pharm Exp Ther 130:389–400Google Scholar
  6. 6.
    Hänze S (1960) Klin Wochenschr 38:1168CrossRefGoogle Scholar
  7. 7.
    Györy AZ, Edwards KDG, Robinson J, Palmer AA (1970) Clin Sci 39:605PubMedGoogle Scholar
  8. 8.
    Becker B (1954) Am J Ophthalm 37:13–15Google Scholar
  9. 9.
    Berson FG (1983) J Toxicol Cut Ocular Toxicol 1:169– 179Google Scholar
  10. 10.
    Laux BE, Raichle ME (1978) J Clin Invest 62:585–592PubMedCrossRefGoogle Scholar
  11. 11.
    Barnish IT, Cross PE, Dickinson RP, Gadsby B, Parry MJ, Randall MJ, Sinclair IW (1980) J Med Chem 23:117–121PubMedCrossRefGoogle Scholar
  12. 12.
    Maren TH, Jankowska L, Sanyal G, Edelhauser HF (1983) Exp Eye Res 36:457–480PubMedCrossRefGoogle Scholar
  13. 13.
    Griggs RC, Engel WK, Resnick JS (1979) Ann Int Med 73:39–48Google Scholar
  14. 14.
    Dalakas H, Engel WK (1983) Muscle and Nerve 6:182–186PubMedCrossRefGoogle Scholar
  15. 15.
    Bauer H, Sturm G (1972) Ärztl Praxis 45:4051Google Scholar
  16. 16.
    Greene MK, Kerr AM, Mcintosh IB, Prescott RJ (1981) Brit Med J 283:811–813CrossRefGoogle Scholar
  17. 17.
    Larson EB, Roach RC, Schoene RB, Hornbein TF (1982) JAMA 248:328–332PubMedCrossRefGoogle Scholar
  18. 18.

Oß/al

  1. 1.
    Matsukawa, Kawasaki, J Pharm Soc Japan 73 (1953), 705, 707, zit. nach CA 48:7017Google Scholar
  2. 2.
    Gauthier et al. (1963) Ann Pharm Franc 21:655PubMedGoogle Scholar
  3. 3.
    Yoshida, Kataoka (1958) Chem Pharm Bl 6:576CrossRefGoogle Scholar
  4. 4.
    Aldrich, Feinchemikalienkatalog 1990–1991Google Scholar

SH

  1. 1.
    Index Nominum (1982)Google Scholar
  2. 2.
    Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Fischer, StuttgartGoogle Scholar

KP

  1. 1.
    Angaben von Rhône Poulenc-RorerGoogle Scholar

SH

  1. 1.
    Mar 29, S.366Google Scholar

vB

  1. 1.
    Clarke EGC (1969) , Isolation and Identification of DrugsGoogle Scholar

Eb/bk

  1. 1.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    Shawinigan Chem. Ltd. (1955) USP 2737528; CA (1956)50:11363Google Scholar
  2. 2.
    Wacker A (1955) DBP 1001249; CA (1984) 101:9043cGoogle Scholar
  3. 3.
    Graselli JG (1974) Atlas of Spectral Data and Physical Constants for Organic Compounds, CRC PressGoogle Scholar

Et

  1. 1.
    White HL, Scates PW (1990) Neurochem Res 15:597–601PubMedCrossRefGoogle Scholar
  2. 2.
    Taglialatela G, Angelucci L, Ramacci MT, Werrbach-Perez K, Jackson GR, Perez-Polo Jr. (1991) Brain Res Dev Brain Res 59:221–230PubMedCrossRefGoogle Scholar
  3. 3.
    Patacchioli FR, Amenta F, Ramacci MT, Taglialatela G, Maccari S, Angelucci L (1989) J Neurosci Res 23:462–466PubMedCrossRefGoogle Scholar
  4. 4.
    Passeri M, Iannuccelli M, Ciotti G, Bonati PA, Nolfe G, Cucinotta D (1988) Int J Clin Pharmacol Res 8:367–376PubMedGoogle Scholar
  5. 5.
    Marciani P, Lindi C, Marzo A, Arrigoni-Martelli E, Cardace G, Esposito G (1991) Pharmacol Res 23:157–162PubMedCrossRefGoogle Scholar
  6. 6.
    Marzo A, Arrigoni-Martelli E, Urso R, Rocchetti M, Rizza V, Kelly JG (1989) Eur J Clin Pharmacol 37:59–63PubMedGoogle Scholar
  7. 7.
    Farrell S, Vogel J, Bieber LL (1986) Biochim Biophys Acta 876:175–177PubMedCrossRefGoogle Scholar
  8. 8.
    Parnetti L, Gaiti A, Mecocci P, Cadini D, Senin U (1992) Eur J Clin Pharmacol 42:89–93PubMedCrossRefGoogle Scholar
  9. 9.
    Kelly JG, Hunt S, Doyle GD, Laher MS, Carmody M, Marzo A, Arrigoni-Martelli E (1990) Eur J Clin Pharmacol 38:309–312PubMedCrossRefGoogle Scholar
  10. 10.
    Herrmann WM, Dietrich B, Hiersemenzel R (1990) Int J Clin Pharmacol Res 10:81–84PubMedGoogle Scholar
  11. 11.
    Vecchi GP, Neri M, Cortelloni C, De Vreese L, Sirotti C, Cipolli C, Fabbri L, Zerbini O (1990) Int J Clin Pharmacol Res 10:145–152PubMedGoogle Scholar
  12. 12.
    Sinforiani E, Iannuccelli M, Mauri M, Costa A, Merlo P, Bono G, Nappi G (1990) Int J Clin Pharmacol Res 10:69–74PubMedGoogle Scholar
  13. 13.
    Rai G, Wright G, Scott L, Beston B, Rest J, Exton-Smith AN (1990) Curr Med Res Opin 11:638–647PubMedCrossRefGoogle Scholar
  14. 14.
    Spagnoli A, Lucca U, Menasce G, Bandera L, Cizza G, Forloni G, Tettamanti M, Frattura L, Tiraboschi P, Comelli M (1991) Neurology 41:1.726–1.732CrossRefGoogle Scholar
  15. 15.
    Bonavita E (1986) Int J Clin Pharmacol Tox 24:511–516Google Scholar

vB

  1. 1.
    Pouchert CJ (1970) Aldrich Library of IR Spectra AIdrich Publ., MilwaukeeGoogle Scholar
  2. 2.
    Pouchert CJ (1974) Aldrich Library of 1H-NMR Spectra Aldrich Publ., MilwaukeeGoogle Scholar
  3. 3.
    Breitmaier E, Voelter W (1990) 13C-NMR Spektroskopie VCH, WeinheimGoogle Scholar
  4. 4.
    Grasseli JG (1973) Atlas of Spectral Data, CRC Pree, New YorkGoogle Scholar

Ws

  1. 1.
    Zimmermann H (1988) Cholinergic synaptic vesicles. In: Whittacker VP (Hrsg.) Cholinerg synapse. Handbook of Exp Pharmacol, Bd.86 Springer, Berlin, S. 349–375CrossRefGoogle Scholar
  2. 2.
    Stroud RM, McCarthy MP, Shuster M (1990) Biochem 29:11009–11023CrossRefGoogle Scholar
  3. 3.
    Hulme EC, Birdsall NJM, Buckley NJ (1990) Ann Rev Pharmacol Toxicol 30:633–673CrossRefGoogle Scholar
  4. 4.
    Ray A, Mac Leod KM (1990) Br J Pharmacol 99:661–666PubMedCrossRefGoogle Scholar
  5. 5.
    Scholz J (1989) Klin Wochenschr 67:271–279PubMedCrossRefGoogle Scholar
  6. 6.
    Furchgott RF, Zawadzki V (1980) Nature 373–376Google Scholar
  7. 7.
    Toda N, Minami Y, Onoue H (1988) Eur J Pharmacol 151:123–126PubMedCrossRefGoogle Scholar
  8. 8.
    Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake K (1990) Hypertension 15:475–481PubMedCrossRefGoogle Scholar
  9. 9.
    Tien XY, Wahawisan R, Wallace LJ, Gaginella TS (1985) Life Sci 36:1949–1955PubMedCrossRefGoogle Scholar
  10. 10.
    Shellenberger K, Walaszek E (1970) Prog Neurol Psychiat 25:106–129Google Scholar
  11. 11.
    Avissar S, Schreiber G, Danon A, Belmaker RH (1988) Nature 331:440–442PubMedCrossRefGoogle Scholar
  12. 12.
    Whittaker VP (1988) Cholinergic false transmitters. In: Whittacker VP (Hrsg.) Handbook of Exp Pharmacol, Bd. 86, Springer, Berlin, S. 465–477Google Scholar

GA

  1. 1.
    Smith HA, Gorin G (1961) J Org Chem 26:820CrossRefGoogle Scholar
  2. 2.
    Helwig H, Otto HH (1990) ArzneimittelGoogle Scholar
  3. 3.
    Merck, Katalog Reagenzien, Diagnostica, Chemikalien 1990/1991Google Scholar
  4. 4.
    Aldrich, Feinchemikalienkatalog 1990/1991Google Scholar
  5. 5.
    Goldenthal EI (1971) Toxicol Appl Pharmacol 18:185PubMedCrossRefGoogle Scholar

SH

  1. 1.
    Scheffner AL, Medler EM, Bailey KR, Gallo DG, Mueller AJ, Sarett HP (1966) Biochem Pharmacol 15:1523–1525CrossRefGoogle Scholar
  2. 2.
    Low PMP, Dulfano MJ, Luk CK, Finch PJP (1985) Ann Allergy 54:273–275PubMedGoogle Scholar
  3. 3.
    Martin R, Litt M, Marriott C (1980) Am Rev Resp Dis 121:495–500PubMedGoogle Scholar
  4. 4.
    Olivieri D, Marisco SA, Donno M Del (1985) Eur J Respir Dis 66 (Suppl. 139):142–145Google Scholar
  5. 5.
    Banda PW, Quart BD (1987) Toxicol Lett 36:89–94PubMedCrossRefGoogle Scholar
  6. 6.
    Prescott LF, Klingworth RN, Critchley JH, Stewart MJ, Adam RD, Proudfoot AT (1979) Br Med J 2:1097–1100PubMedCrossRefGoogle Scholar
  7. 7.
    Prescott LF (1983) Drugs 24:290–314CrossRefGoogle Scholar
  8. 8.
    Sprince H (1985) Eur J Respir Dis 66 (Suppl. 139):102–112Google Scholar
  9. 9.
    Flaherty JT (1989) Drugs 37:523–550PubMedCrossRefGoogle Scholar
  10. 10.
    Szelenyi I, Brune K (1988) Dig Dis Sci 33:863–871CrossRefGoogle Scholar
  11. 11.
    Mereto GC, Balestra L, Henriquet F (1980) Eur J Respir Dis 61 (Suppl. 111):160–165Google Scholar
  12. 12.
    Rodenstein D, Costa A De, Gazzaniga A (1980) Eur J Respir Dis 61 (Suppl. 111):59–60Google Scholar
  13. 13.
    Eichelbaum M (1986) Klinische Pharmakologie. In: Geisler LS (Hrsg.) Rauchen und Atemwege. Prävention und therapeutische Aspekte, Verlag f. angewandte Wissenschaften, München, S. 103–117Google Scholar
  14. 14.
    Maddock J (1980) Eur J Respir Dis 61 (Suppl. 111):52–58Google Scholar
  15. 15.
    Rodenstein D, Costa A De, Gazzaniga A (1978) Clin Pharmacokin 3:247–254CrossRefGoogle Scholar
  16. 16.
    Brochard H, Charpin J, Germouty J (1978) Eur J Respir Dis 61 (Suppl. 111 ):65–69Google Scholar
  17. 17.
    Maesen FPV, Brombacher PJ (1980) Therapiewoche 30:2024–2027Google Scholar
  18. 18.
    Boman G, Bäcker U, Larsson S, Melander B, Wahlander L (1983) Eur J Respir Dis 64:405–415PubMedGoogle Scholar
  19. 19.
    Chodosh S (1989) Eur J Respir Dis 61 (Suppl. 111):169Google Scholar
  20. 20.
    Pilar CE, Engler G, Hochstrasser K (1974) Prax Pneumol 28:841–844Google Scholar
  21. 21.
    Bonanomi L, Gazzaniga A (1980) Eur J Respir Dis 61 (Suppl. 111):45–51Google Scholar
  22. 22.
    Meister R (1986) N-Acetylcystein in der Langzeittherapie chronischer Atemwegserkrankungen. In: Geisler LS (Hrsg.) Rauchen und Atemwege. Prävention und therapeutische Aspekte, Verlag f. angewandte Wissenschaften, München, S. 151–163Google Scholar
  23. 23.
    Ericson D, Schrewelius C, Bratthall D (1988) Eur J Clin Pharmacol 34:201–205PubMedCrossRefGoogle Scholar
  24. 24.
    Guslandi M (1982) Pharmacy intern 3:228–229Google Scholar
  25. 25.
    Bailey DJ, Andres JM (1987) Pediatries 79:281–282Google Scholar

EH

  1. 1.
    Elion GB, Furman PA, Fyfe JA, De Miranda P, Beauchamp L, Schaeffer HJ (1977) Proc Natl Acad Sci USA 74:5.716–5.720CrossRefGoogle Scholar
  2. 2.
    Keller PM, Fyfe JA, Beauchamp L, Lubbers CM, Furman PA, Schaeffer HJ, Elion GB (1981) Biochem Pharmacol 30:3.071–3.077CrossRefGoogle Scholar
  3. 3.
    Davidson RL, Kaufman ER, Crumpacker CS, Schnipper LE (1981) Virology 113:9–19PubMedCrossRefGoogle Scholar
  4. 4.
    Miller WH, Miller RL (1980) J Biol Chem 255:7.204–7.207Google Scholar
  5. 5.
    Derse D, Cheng YC, Furman PA, Clair MH ST, Elion GB (1981) J Biol Chem 256:11.447–11.451Google Scholar
  6. 6.
    Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ (1979) Antimicrob Agents Chemother 15:642–645PubMedCrossRefGoogle Scholar
  7. 7.
    McLaren C, Corey L, Dekket C, Barry DW (1983) J Infect Dis 148:868–875PubMedCrossRefGoogle Scholar
  8. 8.
    Biron KK, Elion GB (1980) Antimicrob Agents Chemother 18:443–447PubMedCrossRefGoogle Scholar
  9. 9.
    Pagano JS,Datta AK (1982) Am J Med 73(Suppl):18–26PubMedCrossRefGoogle Scholar
  10. 10.
    Freitas VR, Smee DF, Chernow M, Boehme R, Matthews TR (1985) Antimicrob Agents Chemother 28:240–245PubMedCrossRefGoogle Scholar
  11. 11.
    Richards DM, Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS (1983) Drugs 26:378–438PubMedCrossRefGoogle Scholar
  12. 12.
    O’Brien JJ, Campoli-Richards DM (1989) Drugs 37:233–309PubMedCrossRefGoogle Scholar
  13. 13.
    Gold D, Corey L (1987) Antimicrob Agents Chemother 31:361–367PubMedCrossRefGoogle Scholar
  14. 14.
    Field HJ, Darby G (1980) Antimicrob Agents Chemother 17:209–216PubMedCrossRefGoogle Scholar
  15. 15.
    Sibrack CD, Gutman LT, Wilfert CM, McLaren C, St Clair MH, Keller PM, Barry DW (1982) J Infect Dis 146:673–682PubMedCrossRefGoogle Scholar
  16. 16.
    Hirsch MS, Schooley RT (1989) N Engl J Med 320:313–314PubMedCrossRefGoogle Scholar
  17. 17.
    Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS (1989) N Engl J Med 320:293–296PubMedCrossRefGoogle Scholar
  18. 18.
    De Miranda P, Blum MR (1983) J Antimicrob Chemother 12(Suppl.B):29–37PubMedCrossRefGoogle Scholar
  19. 19.
    Simon C, Stille W (1989) Antibiotika-Therapie in Klinik und Praxis, 7. Aufl., Schattauer-Verlag, Stuttgart New York, S. 315–321Google Scholar
  20. 20.
    Greife BS,Dooley SL, Deddish RB, Krasny HC (1986) J Pediatr 108:1.020–1.021Google Scholar
  21. 21.
    Lau RJ, Emery MG, Galinski RE (1987) Obstet Gynecol 69:468–471PubMedGoogle Scholar
  22. 22.
    Laskin OL, Longstreth JA, Saral R, De Miranda P, Keeney R, Lietman PS (1982) Antimicrob Agents Chemother 21:393–398PubMedCrossRefGoogle Scholar
  23. 23.
    De Miranda P, Good SS, Kraskny HC, Connor JD, Laskin OL, Lietman PS (1982) Am J Med 73(Suppl):215–220PubMedCrossRefGoogle Scholar
  24. 24.
    Whitley RJ, Blum MR, Barton N, De Miranda P (1982) Am J Med 73(Suppl):165–170PubMedCrossRefGoogle Scholar
  25. 25.
    Dorsky DI, Crumpacker CS (1987) Ann Intern Med 107:859–874PubMedCrossRefGoogle Scholar
  26. 26.
    Freestone DS, Brigden WD (1990) Lancet 335:1.279 (letter)CrossRefGoogle Scholar
  27. 27.
    Jeffries DJ (1986) Brit Med J 293:1.523CrossRefGoogle Scholar
  28. 28.
    Cobo LM, Foulks GN, Liesegang T, Lass UJ, Sutphin JE, Wilhelmus K, Jones DB, Chapman S, Segretti AC, King DH (1986) Ophthalmology 93:763–770PubMedGoogle Scholar
  29. 29.
    Balfour HH Jr., Chace BA, Stapleton JT, Simmons RL, Fryd DS (1989) N Engl J Med 320:1.381–1.387CrossRefGoogle Scholar
  30. 30.
    Gill MJ, Burgess E (1990) J Antimicrob Chemother 25:300–301PubMedCrossRefGoogle Scholar
  31. 31.
    Bean B, Aeppli D (1985) J Infect Dis 151:362–365PubMedCrossRefGoogle Scholar
  32. 32.
    Moore HL Jr., Szczech GM, Rodwell DE, Kapp RW Jr., De Miranda P, Tucker WE Jr. (1983) Fund Appl Toxicol 3:560–568CrossRefGoogle Scholar
  33. 33.
    Stahlmann R, Franz R, Merker HJ (1988a) Naunyn-Schmiedeberg’s Arch Pharmacol 337:R35 (Abstract 138)Google Scholar
  34. 34.
    Stahlmann R, Klug S, Lewandowski C, Bochert G, Chahoud I, Rahm U, Merker HJ, Neubert D (1988b) Arch Toxicol 61:468–479PubMedCrossRefGoogle Scholar
  35. 35.
    Chahoud I, Stahlmann R, Bochert G, Dillmann I, Neubert D (1988) Arch Toxicol 62:8–14PubMedCrossRefGoogle Scholar

st/ST

  1. 1.
    BAz, Nr. 190a vom 10.10.1985 i.d.F. vom BAz, Nr.2 vom 06. 01. 1993Google Scholar

GS

  1. 1.
    BAz, Nr.217a vom 22.11.1985 i.d.F. vom BAz, Nr. 47 vom 08.03.1990Google Scholar

GS

  1. 1.
    BAz, Nr. 66a vom 07.04.1989Google Scholar

GS

  1. 1.
    BAz, Nr. 190a vom 10.10.1985 i.d.F. vom BAz, Nr. 16 vom 24.01.1989Google Scholar

GS

  1. 1.
    BAz,Nr.29a vom 12.02.1986Google Scholar

GS

  1. 1.
    B Az, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    BAz, Nr. 108a vom 19.06.1986Google Scholar

GS

  1. 1.
    BAz, Nr. 242a vom 28.12.1988 i.d.F. vom BAz, Nr. 146 vom 08.08.1989Google Scholar

GS

  1. 1.
    B Az, Nr. 109a vom 16.06.1987Google Scholar

GS

  1. 1.
    BAz, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    B Az, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    BAz, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    BAz, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    BAz, Nr.190a vom 10.10.1985 i.d.F. vom BAz, Nr. 47 vom 08.03.1990 und Beschluß der Kommission D vom Juni 1992, BAz im DruckGoogle Scholar

GS

  1. 1.
    BAz, Nr. 108a vom 19.06.1986Google Scholar

GS

  1. 1.
    BAz, Nr. 109a vom 16.06.1987 i.d.F. vom BAz, Nr. 47 vom 08.03.1990Google Scholar

GS

  1. 1.
    BAz, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    B Az, Nr. 109a vom 16.06.1987Google Scholar

GS

  1. 1.
    BAz, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    BAz, Nr. 109a vom 16.06.1987Google Scholar

SZ

  1. 1.
    Rehm KD, Steinigen M (1982) Pharm Ztg 127 (8):443–446Google Scholar

AG

  1. 1.
    Mooradian AD (1988) Clin Pharmacokinet 15:165–179PubMedCrossRefGoogle Scholar
  2. 2.
    Dengler HJ, Bodem G, Wirth K (1973) Arzneim Forsch 23:64–74Google Scholar
  3. 3.
    Hänel J, Meiffert G (1968) Med Welt 19:54–57Google Scholar
  4. 4.
    Klotz U (1978) -acetyldigoxin from card-hydergine-a fixed combination of hydergine and acetyldigoxin, Int J Clin Pharmacol 16:116–118Google Scholar
  5. 5.
    Kuhlmann J (1985) Clin Pharmacol Ther 37:150–156PubMedCrossRefGoogle Scholar
  6. 6.
    Kuhlmann J, Marcin S (1985) Klin Wochenschr 63:636–642PubMedCrossRefGoogle Scholar
  7. 7.
    Plum J, Daldrup T (1985) Z Rechtsmed 94:257–272PubMedCrossRefGoogle Scholar
  8. 8.
    Rameis H (1985) Europ J Clin Pharmacol 29:29–53CrossRefGoogle Scholar

  1. 1.
    Fieser LF, Fieser M (1961) Steroide, Verlag Chemie, WeinheimGoogle Scholar
  2. 2.
    Gisvold O (1972) J Pharm Sci 61:1320PubMedCrossRefGoogle Scholar
  3. 3.
    Brown L, Cheung HTA, Thomas R, Watson TR (1981) J Chem Soc Perkin Trans 1:1779–1781CrossRefGoogle Scholar
  4. 4.
    Raymond WD (1938) Analyst 63:478 und (1939) 64:113CrossRefGoogle Scholar
  5. 5.
    Keller CC (1895) Ber Dtsch Pharm Ges 5:275 und Kiliani H (1899) Arch Pharm 237:446Google Scholar

AG

  1. 1.
    Raymond WD (1938) Analyst 63:478 und (1939) 64:113CrossRefGoogle Scholar
  2. 2.
    Keller CC (1895) Ber Dtsch Pharm Ges 5:275 und Kiliani H (1899) Arch Pharm 237:446Google Scholar

AG

  1. 1.
    Aposhian HV, Aposhian MM (1959) J Pharmacol exp Ther 126:131–135PubMedGoogle Scholar
  2. 2.
    Aaseth J (1983) Human Toxicol 2:257–272CrossRefGoogle Scholar
  3. 3.
    Pagnotto LD, Brugsch HG, Elkins HB (1960) Am Indust Hyg Ass J 21:419–422PubMedCrossRefGoogle Scholar
  4. 4.
    Hirschman SZ, Feingold M, Boylen G (1963) N Engl J Med 269:889–893PubMedCrossRefGoogle Scholar
  5. 5.
    Parameshvara V (1967) Brit J industr Med 24:73–76PubMedGoogle Scholar
  6. 6.
    Hryhorczuk DO, Meyers L, Chen G (1982) J Toxicol Clin Toxicol 19:401–408PubMedCrossRefGoogle Scholar
  7. 7.
    Smith ADM, Miller JW (1961) Lancet 1961, I, 640–642CrossRefGoogle Scholar
  8. 8.
    Kark RAP, Poskanzer DC, Bullock JD, Boylen G (1971) N Engl J Med 285:10–16PubMedCrossRefGoogle Scholar
  9. 9.
    Markowitz L, Schaumburg HH (1980) Neurology 30:1000–1001PubMedCrossRefGoogle Scholar
  10. 10.
    Gonzalez-Fernandez E, Mena J, Diaz-Gonzalez M,Martinez-Gil de Arana JM (1984) Indust Hlth 22:97–106CrossRefGoogle Scholar
  11. 11.
    Aronow R, Fleischmann LE (1976) Clin Pediatr 15:936–945CrossRefGoogle Scholar
  12. 12.
    Eybl V, Sýkora J, Mertl F (1965) Naunyn-Schmiedebergs Arch exp Path Pharmak 252:79–84Google Scholar
  13. 13.
    Spoerke DG, Smolinske SC, Wruk KM, Rumack BH (1986) Vet Hum Toxicol 28:69–75PubMedGoogle Scholar
  14. 14.
    Stokes GS, Potts JT, Lotz M, Bartter FC (1968) Clin Sci 35:467–477PubMedGoogle Scholar

Fk

  1. 1.
    Rhodes HJ, de Nardo JJ, Bode DW, Blake MI (1975) J Pharm Sci 64:1386–88PubMedCrossRefGoogle Scholar
  2. 2.
    Lin SL (1967) J Pharm Sci 56:1130–40PubMedCrossRefGoogle Scholar
  3. 3.
    Lin SL, Blake MI (1967) J Pharm Sci 56: 43–46PubMedCrossRefGoogle Scholar
  4. 4.
    Woodson AL, Smith DE (1970) Anal Chem 42:242–48PubMedCrossRefGoogle Scholar
  5. 5.
    Hoogmartens J (1984) J Pharm Sci 73:1830–33PubMedCrossRefGoogle Scholar
  6. 6.
    Hoogmartens J (1987) J Chromatogr 388:201–16PubMedCrossRefGoogle Scholar

Eb

  1. 1.
    Hackenthal E (1984) Pharmakologie der antipyretischen Anaigetika. In: Hackenthal E, Wörz R (Hrsg.) Medikamentöse Schmerzbehandlung in der Praxis. Gustav Fischer Verlag, Stuttgart, S. 31–97Google Scholar
  2. 2.
    Rainsford KD, Schweitzer A, Brune K (1983) Biochem Pharmacol 32:1301–1308PubMedCrossRefGoogle Scholar
  3. 3.
    Patrono C (1989) Trends Pharmacol Sci 10:453–458PubMedCrossRefGoogle Scholar
  4. 4.
    Vane Jr. (1971) Nature New Biol 231:232–235PubMedGoogle Scholar
  5. 5.
    Packham MA (1982) Mode of action of acetylsalicylic acid. In: Barnett HJM. Hirsh J, Mustard JF (Hrsg.) Acetylsalicylic acid: New uses for an old drug. Raven Press, New York, S. 63–82Google Scholar
  6. 6.
    Vane Jr. (1987) Drugs 33(suppl.):18–27PubMedCrossRefGoogle Scholar
  7. 7.
    Coceani F, Bishai I, Lees J, Sirko S (1986) Yale J Biol Med 59:169–174PubMedGoogle Scholar
  8. 8.
    Higgs GA, Salmon JA, Henderson B, Vane Jr. (1987) Proc Natl Acad Sci USA 84:1417–1420PubMedCrossRefGoogle Scholar
  9. 9.
    Brune K (1983) Am J Med 75:19–23PubMedCrossRefGoogle Scholar
  10. 10.
    Mitchell D, Laburn HP, Cooper KE, Hellon RF, Cranston WI, Townsend Y (1986) Yale J Biol Med 59:159–168PubMedGoogle Scholar
  11. 11.
    Abramson S, Korchak H, Ludewig R, Edelson H, Haines K, Levin RI, Herman R, Rider L, Kimmel S, Weissmann G (1985) Proc Natl Acad Sci USA 82:7227–7231PubMedCrossRefGoogle Scholar
  12. 12.
    Roth GJ, Siok CJ (1978) J Biol Chem 253:3782–3784PubMedGoogle Scholar
  13. 13.
    Pedersen AK. Fitzgerald GA (1985) Circulation 72:1164–1176PubMedCrossRefGoogle Scholar
  14. 14.
    Clissold SP (1986) Drugs 32 (suppl. 4):8–26PubMedCrossRefGoogle Scholar
  15. 15.
    Levy G (1980) Brit J Clin Pharmacol 10:285–290CrossRefGoogle Scholar
  16. 16.
    Rowland M, Riegelman S, Harris PA, Sholkoff SD (1972) J Pharm Sci 61:379–385PubMedCrossRefGoogle Scholar
  17. 17.
    Needs CJ, Brooks PM (1985) Clin Pharmacokinetics 10:164–177CrossRefGoogle Scholar
  18. 18.
    Gibaldi M, Grundhofer B (1975) J Pharm Sci 64:1064–1066PubMedCrossRefGoogle Scholar
  19. 19.
    Brodgen RN (1986) Drugs 32 (suppl. 4):27–45Google Scholar
  20. 20.
    Hennekens CH, Buring JE, Sandercock P, Collins R, Peto R (1989) Circulation 80:749–756PubMedCrossRefGoogle Scholar
  21. 21.
    Ivey Kj (1986) Drugs 32 (suppl. 4):71–89PubMedCrossRefGoogle Scholar
  22. 22.
    Jick H (1982) Adverse effects of acetylsalicylic acid. In: Barnett HJM, Hirsh JF (Hrsg.) Acetylsalicylic acid: New uses for an old drug, Raven Press, New York, S.239–247Google Scholar
  23. 23.
    Szczeklik A (1986) Drugs 32 (suppl. 4):148–163PubMedCrossRefGoogle Scholar
  24. 24.
    Prescott LF (1986) Drugs 32 (suppl. 4):129–147PubMedCrossRefGoogle Scholar
  25. 25.
    Gladtke E, Schauseil-Zipf U (1987) Monatsschr Kinderheilkd 135:699–704PubMedGoogle Scholar
  26. 26.
    Heimann G (1985) Schmerzbehandlung mit Analgetika in der Pädiatrie. In: Hackenthai E, Wörz R (Hrsg.) Medikamentöse Schmerzbehandlung, Gustav Fischer Verlag, Stuttgart, S.243–273Google Scholar
  27. 27.
    Stuart MJ, Gross SJ, Elrad H, Graeber JE (1982) N Engl J Med 307:909–912PubMedCrossRefGoogle Scholar
  28. 28.
    Heymann MA (1986) Drugs 32 (suppl. 4):164–176PubMedCrossRefGoogle Scholar
  29. 29.
    Späth G (1982) Vergiftungen und akute Arzneimittelüberdosierungen. De Gruyter Verlag, Berlin, S.287–293Google Scholar
  30. 30.
    Brenner BE, Simon RR (1982) Drugs 24:335–340PubMedCrossRefGoogle Scholar
  31. 31.
    Hackenthal E, Wörz R (1985) Analgetika: Irrationale Anwendung, Mißbrauch und Abhängigkeit. In: Hakkenthal E, Wörz R (Hrsg.) Medikamentöse Schmerzbehandlung in der Praxis, Gustav Fischer Verlag, Stuttgart, S.325–373Google Scholar
  32. 32.
    Mihatsch MJ (Hrsg.) (1986) Das Analgetika Syndrom. Thieme-Verlag, Stuttgart, New YorkGoogle Scholar

GS

  1. BAz, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. B Az, Nr. 108a vom 19.06.1986Google Scholar

GS

  1. BAz, Nr. 190a vom 10.10.1985 i.d.F. vom BAz, Nr.47 vom 08.03.1990Google Scholar

GS

  1. BAz, Nr. 109a vom 16.06.1987Google Scholar

GS

  1. BAz, Nr. 108a vom 19.06.1986 GSGoogle Scholar

GS

  1. BAz, Nr. 108a vom 19.06.1986 GSGoogle Scholar

GS

  1. DE 2.319.834 (1973), CA (1974) 80:27294Google Scholar
  2. 2.
    Klein B, Berkowitz J, Hetman NE (1961) J Org Chem 26:126–131CrossRefGoogle Scholar
  3. 3.
    Pitré D,Boveri S, Grabitz EB (1966) Chem Ber 99:364– 367CrossRefGoogle Scholar
  4. 4.
    Agnes G, Felicioli MG, Ribaldone G, Santini C (1988) Chim Ind (Milan) 70:70–71, CA (1988) 109:230945Google Scholar
  5. 5.
    DibbernHW (Hrsg.) (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf 1810Google Scholar
  6. 6.
    Ambrogi V, Cozzi P, Saniust P, Bertone L, Lovisolo PP, Briatico G, Angelucci R (1980) Eur J Med Chem 15:157–163Google Scholar
  7. 7.
    Maggi E, Pianezzola E, Valzelli G (1984) Pharmacol Res Commun 16:1081–1090PubMedCrossRefGoogle Scholar
  8. 8.
    Cozzi P, Pillan A, Bertone L, Branzoli U, Lovisolo PP, Chiari A (1985) Eur J Med Chem 20:241–245Google Scholar

NP/Ba

  1. 1.
    Dukes MNG (1987) Side effects of drugs, Annual 11, Elsevier, Amsterdam New York Oxfort, s. 382Google Scholar
  2. 2.
    Sirtori CR, Gianfranceschi G, Sirtori M, Bernini F, Descovich G, Montaguti U, Fuccella LM, Musatti L (1981) Atherosclerosis 38:267–271PubMedCrossRefGoogle Scholar
  3. 3.
    Jung W, Kohlmeier M, Nikolaus T, Schlierf G (1985) Res Exp Med 185:457–468CrossRefGoogle Scholar
  4. 4.
    Franceschini G, Bernini F, Michelagnoli S, Bellosta S, Vaccarino V, Fumagalli R, Sirtori C (1990) Atherosclerosis 81:41–49PubMedCrossRefGoogle Scholar
  5. 5.
    Musatti L, Maggi E, Moro E, Valzelli G, Tamassi V (1981) J Int Med Res 9:381–386PubMedGoogle Scholar
  6. 6.
    Orsini G, Lovisolo PP, Chiari A, Branzoli U (1985) Pharmacol Res Commun 17:927–936PubMedCrossRefGoogle Scholar

Bj

  1. l. Castaner J (1978) Pro 3:171Google Scholar
  2. 2.
    Ogasawara T, Goto S, Mori S, Oki T (1981) J Antibiotics 34:47–51CrossRefGoogle Scholar

WM

  1. 1.
    Oki T (1977) Jpn J Antibiot 30 Suppl:70–84PubMedGoogle Scholar
  2. 2.
    Seeber S, Loth H, Crooke ST (1980) J Cancer Res Clin Oncol 98:109–118PubMedCrossRefGoogle Scholar
  3. 3.
    Mazzanti L, Scalori V, Mian M, Alessandri MG, Giovannini L (1988) Chemioterapia 7:49–52PubMedGoogle Scholar
  4. 4.
    Ando S, Kamiya K, Yoshimura T, Tsutani H, Ueda T, Uchida M, Nakamura T, Uchino H (1988) Anticancer Res 8:409–415PubMedGoogle Scholar
  5. 5.
    Misumi M, Yamaki H, Akiyama T, Tanaka M (1979) J Antibiot Tokyo 32:48–52PubMedCrossRefGoogle Scholar
  6. 6.
    Someya A, Tanaka N (1979) J Antibiot Tokyo 32:839– 845PubMedCrossRefGoogle Scholar
  7. 7.
    Komiyama T, Oki T, Inui T (1983) Biochim Biophys Acta 740:80–87PubMedCrossRefGoogle Scholar
  8. 8.
    Fourcadc A, Farhi JJ, Bennoun M, Goldschmidt E, Tapiero H (1983) Biochem Pharmacol 32:1.819–1.824Google Scholar
  9. 9.
    Matsuzawa Y, Oki T (1981) J Antibiot 34:1.596–1.607Google Scholar
  10. 10.
    Long BH, Willis CE, Prestayko AW, Crooke ST (1982) Mol Pharmacol 22:152–157PubMedGoogle Scholar
  11. 11.
    Jensen PB, Sorensen BS, Demant EJ, Sehested M, Jensen PS, Vindelov L, Hansen HH (1990) Cancer Res 50:3.311–3.316Google Scholar
  12. 12.
    Traganos F, Staiano-Coico L, Darzynkiewicz Z, Melamed MR (1981) Cancer Res 41:2.728–2.737Google Scholar
  13. 13.
    Tanabe M, Miyamoto T (1983) Gann 74:699–705PubMedGoogle Scholar
  14. 14.
    Schwartz E, Sartorelli AC (1982) Cancer Res 42:2.651–2.655Google Scholar
  15. 15.
    Sakurai M, Sampi K, Hozumi M (1983) Leuk Res 7:139–143PubMedCrossRefGoogle Scholar
  16. 16.
    Ishizuka M, Takeuchi T, Masuda T, Fukasawa S, Umezawa H (1981) J Antibiot Tokyo 34:331–340PubMedCrossRefGoogle Scholar
  17. 17.
    Orbach-Arbouys S, Andrade-Mena CE, Berardet M, Mathe G (1982) Int Arch Allergy Appl Immunol 68:117–121PubMedCrossRefGoogle Scholar
  18. 18.
    Andrade-Mena CE, Orbach-Arbouys S, Mathe G (1986) Chemotherapy 32:142–147PubMedCrossRefGoogle Scholar
  19. 19.
    Iguchi H, Matsushita Y, Ohmori K, Hirano S, Kiyosaki T, Hori S, Tone H, Oki T (1980) Jpn J Antibiot 33:179– 191PubMedGoogle Scholar
  20. 20.
    Tsukagoshi S, Tsuruo T, Yamori T, Iida H, Naganuma K, Sakurai Y (1980) J Pharmacobiodyn 3:532–536PubMedCrossRefGoogle Scholar
  21. 21.
    Fujita H, Ogawa K, Tone H, Iguchi H, Shomura T, Murata S (1986) Jpn J Antibiot 39:1.321–1.336Google Scholar
  22. 22.
    Iguchi H, Seryu Y, Kiyosaki T, Hori S, Tone H, Oki T (1980) Jpn J Antibiot 33:169–178PubMedGoogle Scholar
  23. 23.
    Dodion P, Egorin MJ, Riggs CE Jr., Ferraro TA, Tamburini JM, Bachur NR (1985) Cancer Chemother Pharmacol 15:153–160PubMedCrossRefGoogle Scholar
  24. 24.
    Oki T (1980) Aclacinomycin A. In: Anthracyclines: Current status and new developments, Academic Press, New York London, S. 323–342Google Scholar
  25. 25.
    Miller AA, Benvenuto JA, Casimir MT, Loo TL (1983) Proc 13th Intern Congr Chemother, Wien, Vol. 211:45– 48Google Scholar
  26. 26.
    Ando S, Nakamura T, Kagawa D, Ueda T, Nishimura T, Kubo A, Tustani H, Sasada M, Uchino H (1986) Cancer Treat Rep 70:835–841PubMedGoogle Scholar
  27. 27.
    Karanes C, Young JD, Samson MK, Smith LB, Franco LA, Baker LH (1983) Invest New Drugs 1:173–179PubMedCrossRefGoogle Scholar
  28. 28.
    Komiyama T, Oki T, Inui T, Takeuchi T, Umezawa H (1979) Gann 70:395–401PubMedGoogle Scholar
  29. 29.
    Egorin MJ, Andrews PA, Nakazawa H, Bachur NR (1983) Drug Metab Dispos 11:167–171PubMedGoogle Scholar
  30. 30.
    MachoverD,GastiaburuJ,DelgadoM,GoldschmidtE, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Dorval T, Ribaud P (1984) Biomed Pharmacother 38:328–331PubMedGoogle Scholar
  31. 31.
    Mitrou PS, Kuse R, Anger H, Herrmann R, Bonfert B, Pralle H, Thiel E, Westerhausen M, Mainzer K, Bartels H (1985) Eur J Cancer Clin Oncol 21:919–923PubMedCrossRefGoogle Scholar
  32. 32.
    Takahashi I, Hara M, Ohmoto E, Oda Y, Endo Y, Fujimoto S, Uchida K, Takaoka K, Watanabe S, Lai M, Kohi F, Kitajima K, Kimura I, Sanada H, Tokioka M, Adachi T, Yorimitsu S (1982) Gan To Kagaku Ryoho 9:1.617–1.622Google Scholar
  33. 33.
    Case DC Jr., Boyd MA, Hayes DM (1985) Cancer Treat Rep 69:1.315–1.316Google Scholar
  34. 34.
    Adachi T, Sezaki T, Ishii H, Hasegawa M, Asano K, Takahashi I, Kimura I (1983) Gan To Kagaku Ryoho 10:1.653–1.658Google Scholar
  35. 35.
    Noguchi S, Kubota Y, Shuin T, Miura T, Moriyama M, Sakuramoto T, Oshima H (1984) Hinyokika Kiyo 30:1.153–1.158Google Scholar
  36. 36.
    Ballou RJ, Tseng MT (1986) Urol Res 14:217–222PubMedCrossRefGoogle Scholar
  37. 37.
    Casper ES, Gralla RJ, Young CW (1981) Cancer Res 41:2.417–2.420Google Scholar
  38. 38.
    Poochikian GK, Cradock JC, Flora KP (1981) Am J Hosp Pharm 38:483–486PubMedGoogle Scholar
  39. 39.
    Woolley PV, Ayoob MJ, Levenson SM, Smith FP (1982) J Clin Pharmacol 22:359–365PubMedCrossRefGoogle Scholar
  40. 40.
    Rainer H, Gossinger H, Lenzhofer R, Moser K, Schneeweiss B (1983) Wien Med Wochenschr 133:183–187PubMedGoogle Scholar
  41. 41.
    Kobayashi M, Tahara T (1983) Gan To Kagaku Ryoho 10:1.473–1.479Google Scholar
  42. 42.
    Kobayashi Y, Usuda Y, Okutu Y, Okumura F, Suzuki H, Yoshida G, Hayakawa J, Shibata T (1990) Masui 39:651–655PubMedGoogle Scholar
  43. 43.
    Iwata N, Karasawa M, Omine M, Maekawa T, Suzuki T, Kawai Y (1984) Cancer Treat Rep 68:527–529PubMedGoogle Scholar
  44. 44.
    Furue H, Komita T, Nakao I, Furukawa I, Kanko T, Yokoyama T (1978) Recent Results Cancer Res 63:241– 246PubMedGoogle Scholar
  45. 45.
    Ohmori K, Hirano S, Kiyosaki T, Hori S, Tone H (1980) Jpn J Antibiot 33:453–465PubMedCrossRefGoogle Scholar
  46. 46.
    Warrell RP, Arlin ZA, Kempin SJ, Young CW (1982) Cancer Treat Rep 66:1.619–1.623Google Scholar
  47. 47.
    Umezawa K, Sawamura M, Matsushima T, Sugimura T (1978) Cancer Res 38:1.782–1.784Google Scholar
  48. 48.
    Oki T, Takeuchi T, Oka S, Umezawa H (1981) New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials. In: Carter S, Sukurai Y, Umezawa H (Hrsg.) Recent Results Cancer Res, Springer, Berlin Heidelberg New York, S. 21–40Google Scholar
  49. 49.
    Marzin D, Jasmin C, Maral R, Mathe G (1983) Eur J Cancer Clin Oncol 19:641–647PubMedCrossRefGoogle Scholar
  50. 50.
    Westendorf J, Marquardt H, Ketkar MB, Mohr U, Marquardt H (1983) Cancer Res 43:5.248–5.251Google Scholar
  51. 51.
    Shuin T, Moriyama M, Nishimura R, Takai S, Umeda M(1981) Gann 72:197–204PubMedGoogle Scholar

Mw

  1. 1.
    Moffat Ac (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, The Parmaceutical Press, LondonGoogle Scholar
  2. 2.
    Pelletier SW, Djarmati Z (1976) J Am Chem Soc 98:2626–2636CrossRefGoogle Scholar

AG

  1. BAz, Nr. 66a vom 07.04.1989Google Scholar

GS

  1. 1.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Nr. 902Google Scholar

Eb/hn

  1. 1.
    Kramer A, Wallhäußer KH (1993) Wirkungsspektrum und Anwendungseigenschaften häufig aus prophylaktischer Indikation angewendeter Antiseptika. In: Kramer A, Weuffen W, Gröschel D, Heeg P, Hingst V, Lippert H, Rotter M (Hrsg.) Klinische Anwendung von Antiseptika, Springer Verlag, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona, S. 33–34CrossRefGoogle Scholar
  2. 2.
    Kramer A, Böttcher I, Böttcher U, Niesler M, Neumann K, Weuffen W (1990) Antiseptische Effektivität ausgewählter Antiseptika zur prophylaktischen Mundhöhlenspülung. In: Knoll KH (Hrsg.) Angewandte Hygiene in ZMK-Klinik und Praxis, Med Zentrum für Hyg u Med Mikrobiol der Philipps-Univ, Marburg, S. 211–217Google Scholar
  3. 3.
    Kramer A, Kedzia W, Lebek G, Grün L, Weuffen W, Poczta A (1984) In-vitro-und In-vivo-Befunde zur Resistenzsteigerung bei Bakterien gegen Antiseptika und Desinfektionsmittel. In: Krasilnikow AP, Kramer A, Gröschel D, Weuffen W (Hrsg.) Faktoren der mikobiellen Kolonisation, Handbuch der Antiseptik, Volk und Gesundheit, Bd. I/4, Berlin, S. 87Google Scholar
  4. 4.
    Mohn G (1971) Arch Toxicol 28:93–104CrossRefGoogle Scholar
  5. 5.
    Brown BR, Firth WJ, Yielding LW (1980) Mut Res 72:373–388CrossRefGoogle Scholar
  6. 6.
    Nasim A, Brychcy T (1979) Mut Res 65:261–288CrossRefGoogle Scholar
  7. 7.
    Bandemir G, Pambor M (1985) Toxische (irritative) Nebenwirkungen von Antiseptika an der Haut. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Toxische und allergische Nebenwirkungen von AntiseptikaGoogle Scholar
  8. Handbuch der Antiseptik, Bd. I/5, Volk und Gesundkeit, Berlin, S. 308 8. Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 142–145Google Scholar

ak

  1. Prüfvorschrift Pharma Stulln GmbH, Stulln/NabburgGoogle Scholar

kr

  1. 1.
    Olah JA, Olah GA (1973) Synthesis 488Google Scholar
  2. 2.
    Graselli JG (1974) Atlas of Spectral Data and Physical Constants for Organic Compounds, CRC PressGoogle Scholar
  3. 3.
    Stetter H, Mayer J, Schwarz M, Wulff C (1960) Chem Ber 93:226–230CrossRefGoogle Scholar

Et

  1. 1.
    Wagner J, Hirth Y, Claverie N, Danzin C (1986) Anal Biochem 154:604–617PubMedCrossRefGoogle Scholar

JM/W

  1. Usdin E, Borchardt RT, Crewling C (1982) Pitman Press, BathGoogle Scholar
  2. 2.
    Gualano M, Berti F, Stramentinoli G (1985) Int J Tiss React VII(l): 41–46Google Scholar
  3. 3.
    Bird J, Mohd-Hidir S, Lewis DA (1983) Agents Actions 12:342–347CrossRefGoogle Scholar
  4. 4.
    Oyanagui J (1984) Agents Actions 14:228–237PubMedCrossRefGoogle Scholar
  5. 5.
    Genedani S, Piccinini J, Bertolini A (1984) Life Sci 34:2.407–2.412CrossRefGoogle Scholar
  6. 6.
    Cimino M, Vantini G, Algeri S, Curatola G, Pezzoli C, Stramentinoli G (1984) Life Sci 34:2.029–2.039CrossRefGoogle Scholar
  7. 7.
    Harmand MF, Vilamitjana J, Maloche E, Duphil R, Ducasson D (1987) Am J Med 83(Suppl.5A):48–54PubMedCrossRefGoogle Scholar
  8. 8.
    Barcelo HA, Wiemeyer JCM, Sagasta CL, Macias M, Barreira JC (1987) Am J Med 83(Suppl. 5A):55–59PubMedCrossRefGoogle Scholar
  9. 9.
    Rudorfer MV, Potter WZ (1989) Drugs 37:713–738PubMedCrossRefGoogle Scholar
  10. 10.
    Baldessarini RJ (1987) Am J Med 83(Suppl.5A):95– 103PubMedCrossRefGoogle Scholar
  11. 11.
    Janicak PG, Lipinski J, Davis JM, Comaty JE, Waternaux C, Cohen B, Altman E, Sharma RP (1988) Alabama J Med Sci 25:306–313Google Scholar
  12. 12.
    Lieber CS, Williams R (1990) Drugs 40(Suppl. 3):1–138PubMedGoogle Scholar
  13. 13.
    Di Padova C (1987) Am J Med 83(Suppl.5A):60–65PubMedCrossRefGoogle Scholar

Sm/KA

  1. Boehringer Mannheim FirmenmitteilungGoogle Scholar
  2. 2.
    Kranen-Fiedler U (1955) Arzneim Forsch 5:757–758Google Scholar

EK

  1. 1.
    Shaw G (1980) Purines and Related Ring Systems. In: Coffey S(Hrsg.) Rodd’s Chemistry of Carbon Compounds, 2. Aufl., Bd. IV, Part C Suppl. Elsevier, Amsterdam, S. 1Google Scholar
  2. Boehringer Mannheim PrivatmitteilungGoogle Scholar
  3. 3.
    Harkins ThR, FreiserF (1958) J Am Chem Soc 80: 1132–1135CrossRefGoogle Scholar
  4. Eigene UntersuchungGoogle Scholar
  5. 5.
    Kranen-Fiedler U (1955) Arzneim Forsch 5:757–758Google Scholar

EK

  1. 1.
    Newby AC (1984) Trends Biochem Sci 9:42–44CrossRefGoogle Scholar
  2. 2.
    Hanley FL, Grattan MT, Hoffman JI (1986) Am J Physiol 250:H558–H566PubMedGoogle Scholar
  3. 3.
    Merrill GF, Downey HF, Jones CE (1986) Am J Physiol 250:H579–H583PubMedGoogle Scholar
  4. 4.
    Sollevi A, Torsseil L, Owall A, Edlund A (1986) Pflügers Arch 407 (Suppl 1):25SGoogle Scholar
  5. 5.
    Watt AH, Routledge PA (1986) Br Med J 293:1.455– 1.456Google Scholar
  6. 6.
    Berne RM (1980) Circ Res 47:807–813PubMedCrossRefGoogle Scholar
  7. 7.
    Winn HR, Morii S (1985) Ann Biomed Eng 13:321– 328PubMedCrossRefGoogle Scholar
  8. 8.
    Dobson JG Jr., Rubio R, Berne RM (1971) Circ Res 29:375–384PubMedCrossRefGoogle Scholar
  9. 9.
    Fukunaga AF, Flacke WE, Bloor BC (1982) Anesth Analg 61:273–278PubMedCrossRefGoogle Scholar
  10. 10.
    Spielman WS, Thompson CI (1982) Am J Physiol 242:F423–F435PubMedGoogle Scholar
  11. 11.
    Daly JW, Bruns RF, Snyder SH (1981) Life Sci 28:2.083–2.087CrossRefGoogle Scholar
  12. 12.
    Dragunow M (1986) Trends Pharmacol Sci 7:128–130CrossRefGoogle Scholar
  13. 13.
    Born GVR, Honour AJ, Mitchell Jr.A (1964) Nature 202:761–765PubMedCrossRefGoogle Scholar
  14. 14.
    Reid PG, Watt AH, Routledge PA, Smith AP (1987) Br J Clin Pharmac 23:331–338CrossRefGoogle Scholar
  15. 15.
    Cushley MJ, Tattersfield AE, Holgate ST (1984) Am Rev Respir Dis 129:380–384PubMedGoogle Scholar
  16. 16.
    Stiles GL (1986) Trends Pharmacol Sci 7:486–490CrossRefGoogle Scholar
  17. 17.
    Klabunde RE (1983) Eur J Pharmacol 93:21–26PubMedCrossRefGoogle Scholar
  18. 18.
    Sollevi A, Lagerkranser M, Irestedt L, Gordon E, Lindquist C(1984) Anesthesiology 61:400–405PubMedCrossRefGoogle Scholar
  19. 19.
    Watt AH, Bernard MS, Webster J, Passani SL, Stephens MR, Routledge PA (1986) Br J Clin Phramacol 21:227–230CrossRefGoogle Scholar
  20. 20.
    Clarke B, Rowland E, Barnes PJ, Till J, Ward DE, Shinebourne EA (1987) Lancet I:299–300CrossRefGoogle Scholar
  21. 21.
    Sylvén C, Beermann B, Jonzon B, Brandt R (1986) Br Med J 293:227–230CrossRefGoogle Scholar

EH

  1. l.Mar29,S. 1.492Google Scholar
  2. 2.
    Saito D, Ueeda M, Abe Y, Tani H, Nakatsu T, Yoshida H, Hraoka S, Nagashima H (1986) Br Heart J 55:291–294PubMedCrossRefGoogle Scholar

EH

  1. 1.
    Embden, Zimmermann (1927) Z Physiol Chem 167:137CrossRefGoogle Scholar
  2. Mitteilung der Firma Pharma Waldhof-GmbHGoogle Scholar
  3. 3.
    Pouchert CJ (1985) The Aldrich Library of FT-IR Spectra, 1. Aufl., Bd.2, Aldrich Chemical Company Inc. Wilwaukee, USAGoogle Scholar

SH

  1. 1.
    Beihassen B,Pelleg A (1984) J Am Coll Cardiol 4:414– 424CrossRefGoogle Scholar
  2. 2.
    Urthaler F, James TN (1972) J Lab Clin Med 79:96–105PubMedGoogle Scholar
  3. 3.
    Belardinelli L, Belloni FL, Rubio R, Berne RM (1980) Circ Res 47:684–691PubMedCrossRefGoogle Scholar
  4. 4.
    DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L (1983) Circulation 68:1.254–1.263CrossRefGoogle Scholar
  5. 5.
    Blue WT, Winland RG, Stobbs DG (1981) Antimicrob Agents Chemother 20:547–548PubMedCrossRefGoogle Scholar
  6. 6.
    Blue WT, Macias EA, Sklar SH (1983) Antimicrob Agents Chemother 24:807–809PubMedCrossRefGoogle Scholar
  7. 7.
    Sklar SH, Buimovici-Klein E (1979) Oral Surg 48:416– 417PubMedCrossRefGoogle Scholar
  8. 8.
    Sklar SH, Blue WT, Alexander EJ, Bodian CA (1985) JAMA 253:1.427–1.430Google Scholar
  9. Mar 29, S. 1.492Google Scholar
  10. Gajdos A (1974) Lancet 2:163CrossRefGoogle Scholar

EH

  1. 1.
    Kerr SE (1941) J Biol Chem 139:131Google Scholar
  2. Shaw G (1980) Purines and Related Ring Systems In: Coffey S (Hrsg.) Rodd’s Chemistry of Carbon Compounds, Bd. V, Teil C Suppl., 2. Aufl., Elsevier, Amsterdam, S. 11Google Scholar
  3. Mitteilungen der Firma Boehringer MannheimGoogle Scholar

EK

  1. 1.
    Losstick R (1980) Nucleosides, Nucleotides and Nucleic Acids. In: Coffey S (Hrsg.) Rodd’s Chemistry of Carbon Compounds 2. Aufl., Bd. VI, Part C Suppl Elsevier, Amsterdam, S. 61Google Scholar
  2. 2.
    Breitmaier E, Haas G, Voelter W (1979) Atlas of Carb-on-13 NMR Data, Bd. 2, Heyden and Son Ltd. London, Nr.3001 EKGoogle Scholar
  3. 1.
    Mar 29, S. 1.492Google Scholar
  4. 2.
    Saito D, Ueeda M, Abe Y, Tani H, Nakatsu T, Yoshida H, Haraoka S, Nagashima H (1986) Br Heart J 55:291– 294PubMedCrossRefGoogle Scholar
  5. 3.
    Beihassen B, Pelleg A (1984) J Am Coll Cardiol 4:414– 424CrossRefGoogle Scholar
  6. 4.
    Urthaler F, James TN (1972) J Lab Clin Med 79:96–105PubMedGoogle Scholar
  7. 5.
    Ronca-Testoni S, Broghini F (1982) J Mol Cell Cardiol 14:177–180PubMedCrossRefGoogle Scholar

EH

  1. Eigene UntersuchungenGoogle Scholar
  2. Mitteilung der Firma Boehringer MannheimGoogle Scholar

EK

  1. 1.
    Lu MC, Wung WE, Shih LB, Callejas S, Gearien JE, Thompson EB (1987) J Med Chem 30:273–278PubMedCrossRefGoogle Scholar
  2. 2.
    Jugelt W (1971) Z Chem 11:174–175CrossRefGoogle Scholar

gs

  1. 1.
    Lehmann G, Knoeffel PK (1942) J Pharmac exp Ther 74:274–283Google Scholar
  2. 2.
    Delmendo RE, Michel AD, Whiting RL (1989) Br J Pharmacol 96:457–464PubMedCrossRefGoogle Scholar
  3. 3.
    Michel AD, Whiting RL (1987) Br J Pharmacol 92:755–767PubMedCrossRefGoogle Scholar
  4. 4.
    Michelot J, Moreau MF, Veyre A, Labarre P, Meyniel G 81985) Eur J Drug Metab Pharmacokinet 10:273– 278PubMedCrossRefGoogle Scholar
  5. 5.
    Michelot J, Madelmont JC, Jordan D, Mornex R, Meyniel G(1981) Xenobiotica 11:123–130PubMedCrossRefGoogle Scholar
  6. 6.
    Michelot J, Madelmont JC, Rousset B, Labarre P, Mornex R, Meyniel G (1982) Xenobiotica 12:457–462PubMedCrossRefGoogle Scholar
  7. 7.
    Jordan D, Ponsin G, Mornex R (1976) Int Congr Ser-Excerpta Med 378:18–20Google Scholar
  8. 8.
    Fevre M, Jordan D, Tourniaire J, Mornex R (1979) Can J Physiol Pharmacol 57:1.388–1.392CrossRefGoogle Scholar
  9. Mar 28, S. 293Google Scholar

RJ

  1. 1.
    Lu MC, Wung WE, Shih LB, Callejas S, Gearien JE, Thompson EB (1987) J Med Chem 30:273–278PubMedCrossRefGoogle Scholar
  2. 2.
    Fontani F, Marai A, Sbarbaro F (1971) Il Farmaco Ed Sci 26:329–332Google Scholar
  3. 3.
    Attwood D (1976) J Pharm Pharmacol 28:407–409PubMedCrossRefGoogle Scholar
  4. 4.
    Belikov VG (1972) J Appl Chem USSR 45:1203–1206Google Scholar
  5. 5.
    Stead AH, Gill R, Wright T, Gibbs JP, Moffat AC (1982) Analyst 107:1106–1168PubMedCrossRefGoogle Scholar
  6. 6.
    Taha AM, El-Kader MA (1979) J Chromatogr 177: 405–408PubMedCrossRefGoogle Scholar
  7. 7.
    Clarke EGC (1969) Isolation and Identification of Drugs, Vol. I, The Pharmaceutical Press, London, S.110Google Scholar
  8. 8.
    Dutt MC (1982) J Chromatogr 248:115–124CrossRefGoogle Scholar
  9. 9.
    Lobanov VI, Shevtsov A (1987) Otkrytiya Izobret 42: 166, CA 110:P68790cGoogle Scholar
  10. 10.
    Brown ND, Scovill JP, Sleeman HK, Doctor BP (1980) J Chromatogr 200:267–270CrossRefGoogle Scholar

gs

  1. 1.
    Foerst W (1953) Ulimanns Enzyklopädie der technischen Chemie, Bd. 3, Urban und Schwarzenberg, München Berlin, S. 92–96Google Scholar
  2. 2.
    Gillman H, Blatt AH (1948) Organic Syntheses Coll, 18.-20. Aufl., Bd. I, John Wiley and Sons New YorkGoogle Scholar
  3. Pouchert ChJ (1970) The Aldrich Library of Infrared SpectraGoogle Scholar

Et

  1. Ana 3, 333–363Google Scholar

Eb/kb

  1. l.Mar 29, S. 866Google Scholar

vB

  1. 1.
    Stolz F (1904) Ber 37:4149–4152Google Scholar
  2. Privatmitteilung Sertürner Arzneimittel GmbH, GüterslohGoogle Scholar

QO

  1. 1.
    Kleemann A, Engel J (1982) Pharmazeutische Wirkstoffe: Synthesen, Patente, Anwendungen, 2. Aufl., Georg Thieme Verlag, Stuttgart New YorkGoogle Scholar
  2. 2.
    Stolz F (1904) Ber 37:4.149–4.152Google Scholar
  3. BudavariS, The Merck Index (1989) 11. Auflage,Merck & Co. Inc., Rahway New Jersey 4. Privatmitteilung Sertürner Arzneimittel GmbH-GüterlohGoogle Scholar

QO

  1. 1.
    Hampel H, Hofrichter G, Liehn HD, Schlemmer W (1970) Arzneim Forsch 20:209–215Google Scholar
  2. 2.
    Vogel G, Marek ML (1962) Arzneim Forsch 12:815– 825Google Scholar
  3. 3.
    Hladovec J (1977) Arzneim Forsch 27:1073–1076Google Scholar
  4. 4.
    Torel J, Cillard J, Cillard P (1986) Phytochem 25:383– 385CrossRefGoogle Scholar
  5. 5.
    Pillner NB (1977) Arzneim Forsch 27:1069–1073Google Scholar
  6. 6.
    Moroney MA, Alcaraz MJ, Forder RA, Carey F, Hoult Jr.S (1988) J Pharm Pharmacol 40:787–792PubMedCrossRefGoogle Scholar
  7. 7.
    Alcaraz MJ, Hoult Jr.S (1985) Arch Int Pharmacodyn Ther 278:4–12PubMedGoogle Scholar
  8. 8.
    Bisler H, Pfeifer R, Klüken N, Pauschinger RP (1986) Dtsch Med Wochenschr 111:1321–1329PubMedCrossRefGoogle Scholar
  9. 9.
    Henschler D, Hempel K, Schultze B, Maurer W (1971) Arzneim Forsch 21:1682–1692Google Scholar
  10. 10.
    Kunz K, Schaffler K, Biber A, Wauschkuhn CH (1991) Pharmazie 46:145PubMedGoogle Scholar
  11. 11.
    Fischer H (1984) Therapiewoche 34:4104–4106Google Scholar
  12. 12.
    Felix W (1986) Therapiewoche 36:1083–1089Google Scholar
  13. 13.
    Erler M (1991) Medwelt 42:593–596Google Scholar
  14. 14.
    Ockelford PA, Hull R (1982) Drugs 24:152–162PubMedCrossRefGoogle Scholar
  15. 15.
    Takegoshi K, Tohyama T, Okuda K, Suzuki K, Ohta G (1986) Gastroenterol Japon 21:62–65Google Scholar
  16. 16.
    Schweitzer H (1952) Med Klin 47:683–685Google Scholar
  17. 17.
    Lorenz D, Marek ML (1960) Arzneim Forsch 10:263– 273Google Scholar

GA

  1. 1.
    Haley TJ, Clark WG, Geissman TA (1947) Proc Soc Exp Biol Med 65:202–207PubMedGoogle Scholar
  2. 2.
    Gabor M (1972) (Hrsg.) The antiinflammatory action of flavonoids, Akadémi Kiadó, BudapestGoogle Scholar
  3. 3.
    Beiler JM, Martin GJ (1948) J Biol Chem 174:31–35PubMedGoogle Scholar
  4. 4.
    Masquelter J (1951) Bull Sté Chim Biol 33:302–303Google Scholar
  5. 5.
    Böhm K (1960) Arzneim Forsch 10:54–58Google Scholar
  6. 6.
    Ibe BO, Falck Jr., Johnson AR, Campbell WB (1989) Am J Physiol 256:0168–0175Google Scholar
  7. 7.
    Hsien RJ, German JB, Kinsella JE (1988) Lipids 23:322–326CrossRefGoogle Scholar
  8. 8.
    Speranskaya TV, Gorizotova MP, Alexandrov PN (1988) Patol Fiziol Eksp Ter 55–58Google Scholar
  9. 9.
    Trepeta RW, Edberg SC (1987) Anatonie van Leuwenhoek 53:273–277CrossRefGoogle Scholar
  10. 10.
    Voelkel A (1953) Ärztl Forsch 7:228–234Google Scholar
  11. 11.
    Mith RB, Moodie J (1988) Curr Med Res Opin 11:34– 40CrossRefGoogle Scholar
  12. 12.
    Comaish JS, Kersey PJ (1980) Contact dermatitis 6:150–151PubMedCrossRefGoogle Scholar

GA

  1. 1.
    BAz, Nr. 160 vom 28.08.1990Google Scholar

GS

  1. 1.
    BAz, Nr.213a vom 11.11.1989Google Scholar

GS

  1. 1.
    MI 11, S. 171Google Scholar

vB

  1. 1.
    Anit FAL, Robinson R (1954) J Chem Soc:1.242Google Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widopp B (Hrsg.) (1986) Clark’s Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Jane J et al (1985) J Chromatogr 323:191–225PubMedCrossRefGoogle Scholar

ms

  1. 1.
    Vaughan Williams EM (1975) Pharmac Ther B1:115– 138Google Scholar
  2. 2.
    Kuschinsky G, Reuter H (1961) N S Arch Pharmakol 242:17–23Google Scholar
  3. 3.
    Tritthart H, Fleckenstein B, Fleckenstein A (1971) N S Arch Pharmacol 269:212–219CrossRefGoogle Scholar
  4. 4.
    Pillat B, Heistracher P (1964) N S Arch Pharmacol 246:375–388CrossRefGoogle Scholar
  5. 5.
    Benthe HF (1956) N S Arch Pharmacol 229:82–91Google Scholar
  6. 6.
    Saetre H, Ahlmark G, Ahlberg G (1974) Eur J Clin Pharmacol 7:253–257PubMedCrossRefGoogle Scholar
  7. 7.
    Sowton E, Sullivan ID, Crick JPC (1984) Eur J Clin Pharmacol 26:147–150PubMedCrossRefGoogle Scholar
  8. 8.
    Kleinsorge H, Gaida P (1962) Klin Wschr 40:149–151PubMedCrossRefGoogle Scholar
  9. 9.
    Hamm J, Deiwick HJ, Renschler HE, Zack WJ (1960) Verh Dtsch Ges Kreislaufforsch 26:273–276PubMedGoogle Scholar
  10. 10.
    Klein G, Wirtzfeld A, Schlegel J, Himmler C, Neiß A (1980) Dtsch Med Wschr 105:189–194PubMedCrossRefGoogle Scholar
  11. 11.
    Kleinsorge H, Gaida P (1961) Arzneim Forsch 11:1.100–1.102Google Scholar
  12. 12.
    Forster G, Holzmann M (1966) Schweiz Med Wschr 97:185–193Google Scholar
  13. 13.
    Schroder R, Dissmann W, Buschmann HJ, Schneider J (1966) Dtsch med Wschr 91:2.022–2.031Google Scholar
  14. 14.
    Gleichmann U, Seipel L (1973) Med Welt 24:998–999PubMedGoogle Scholar
  15. 15.
    Greandier E, Alpan G, Keidar S, Weiss D, Marmor A, Palant A (1983) Angiology 34:204–214CrossRefGoogle Scholar
  16. 16.
    Schreiber FK (1962) Med Welt 8:426–436PubMedGoogle Scholar
  17. 17.
    Manz M, Lüderitz B (1988) Deutsch Med Wschr 113:1.317–1.321CrossRefGoogle Scholar
  18. 18.
    Wellens HJJ, Bär FW, Vanagt EJ (1980) Am J Cardiol 45:905PubMedCrossRefGoogle Scholar
  19. 19.
    Kaul U, Mohan JC, Narula J, Nath CS, Bhatia ML (1985) Cardiology 72:140–143PubMedCrossRefGoogle Scholar
  20. 20.
    Rosenkranz KA (1962) Dtsch Med Wschr 87:23–27PubMedCrossRefGoogle Scholar
  21. 21.
    Frank A, Kindermann G (1962) Dtsch Med Wschr 87:225PubMedCrossRefGoogle Scholar
  22. 22.
    Peresecenschi G, Eidelman B (1981) Curr Ther Res 30:483–488Google Scholar
  23. 23.
    Larrey D, Pessayre D, Duhamel G, Casier A, Degott C, Feldmann G, Erlinger S, Benhamou JP (1986) J Hepatol 2:81–87PubMedCrossRefGoogle Scholar
  24. 24.
    Spiel R, Enenkel W, Fischer M (1977) Z Kardiol 66:402–404PubMedGoogle Scholar
  25. 25.
    Hor R, Okumura K, Inui KI, Yasuhara M, Yamada K, Sakurai T, Kawai C (1983) J Pharm Pharmacol 36:202– 204CrossRefGoogle Scholar
  26. 26.
    Koppel C, Wagemann A, Martens F (1989) European Journal of Drug Metabolism and Pharmacokinetics 142:161–167CrossRefGoogle Scholar

Kg/gl

  1. 1.
    Pouchert ChJ (1970) The Aldrich Library of Infrared SpectraGoogle Scholar
  2. 2.
    Pouchert ChJ, Campbell Jr. (1974) The Aldrich Library of NMR SpectraGoogle Scholar

Et

  1. 1.
    Buddecke E: W de Gruyter Verlag, Berlin, 8. Auflage (1989) Grundriß der BiochemieGoogle Scholar
  2. 2.
    Bürger U (1977) Infusionstherapie 4:273–279Google Scholar
  3. 3.
    Jürgens P, Dolif D (1968) Klin Wschr 46:131PubMedCrossRefGoogle Scholar
  4. 4.
    Patra F, Sack D, Islam A, Alam A, Mazumder R (1989) BMJ 298:1.353–1.356CrossRefGoogle Scholar
  5. 5.
    Wapnir R, Zdanowicz M, Teichberg S, Lifshitz F (1988) Am J Clin Ntr. 48:84–90Google Scholar
  6. 6.
    Hattori T, Hotta N, Ohara K, Shinoda H, Kunieda T, Nomura T, Kakuta H, Tamagawa T, Sakamoto N (1989) Nagoya J Med Sci 51:7–16PubMedGoogle Scholar
  7. 7.
    Miyagi N (1989) Nippon Shokakibyo Gakkai Zasshi 86:2.523–2.531Google Scholar
  8. 8.
    Myrvold H, Stein T, Wise L (1988) Eur Surg Res 20:205–210PubMedCrossRefGoogle Scholar
  9. 9.
    Bässler K-H, Fekl W, Lang K (1973) Grundbegriffe der Ernährungslehre, Springer, Berlin HeidelbergCrossRefGoogle Scholar
  10. 10.
    Wissenschaftliche Tabellen Geigy, Ciba-Geigy-Verlag, Basel, 8. Auflage (1979)Google Scholar
  11. 11.
    Bürger U (1985) Untersuchungen über die Verwertung parenteral zugeführter Aminosäuren. In: Klinische Ernährung, 13.W, Zuckschwerdt-Verlag, MünchenGoogle Scholar
  12. 12.
    Kleinberger G, Bürger U (1985) Aminosäurentrans-ferlösungen. In: Reihe Klinische Ernährung 15.W, Zuckschwerdt-Verlage, MünchenGoogle Scholar

bu

  1. 1.
    Cook, GC (1990) Parasitol Today 6:133–136PubMedCrossRefGoogle Scholar
  2. 2.
    Campbell WC (1990) Parasitol Today 6:130–133PubMedCrossRefGoogle Scholar
  3. 3.
    Bruce JI (1987) Int J Parasitol 17:132–133CrossRefGoogle Scholar
  4. 4.
    Bossche H van den (1985) Pharmacology of anthelmintics. In: Bossche H van den, Thienport D, Janssens PG (Eds.) Chemotherapy of gastrointestinal helminths, Springer, New York, p. 125–181CrossRefGoogle Scholar
  5. 5.
    Lacey E (1990) Parasitol Today 6:112–115PubMedCrossRefGoogle Scholar
  6. 6.
    Ireland M, Gull K, Gutteridge WE, Pogson CI (1979) Biochem Pharmacol 28:2680–2682PubMedCrossRefGoogle Scholar
  7. 7.
    McCracken RO, Stillwell WH, Hudson HM (1982) Molec Biochem Parasitol (Suppl.):726Google Scholar
  8. 8.
    Barrowman MM, Marriner SE, Bogan JA (1984) Biosci Rep 4:879–884PubMedCrossRefGoogle Scholar
  9. 9.
    Robertson EL (1988) Chemotherapy of parasitic diseases. In: Booth NH, McDonald LE (Eds.) Veterinary Pharmacology and Therapeutics, Iowa State University Press, Ames, p. 877–968Google Scholar
  10. 10.
    Botero D (1986) Nematode infections of man, intestinal infections. In: Campbell WC, Rew RS (Eds.) Chemotherapy of parasitic diseases, Plenum Press, New York London, p. 267–276CrossRefGoogle Scholar
  11. 11.
    Gottschall DW, Theodorides VJ, Wang R (1990) Parasitol Today 6:115–124PubMedCrossRefGoogle Scholar
  12. 12.
    Rossignol JG, Maisonneure H (1984) Gastroenterol Clin Biol 8:569–576PubMedGoogle Scholar

ha

  1. 1.
    Buu-Hoi NP, Lambelin G, Gillet C, Roba J, Staquet M, (1969) Naturw 56:330–331CrossRefGoogle Scholar

Ub

  1. 1.
    Brogden RN, Heel RC, Speight TM, Avery GS (1977) Drugs 14:241–259PubMedCrossRefGoogle Scholar
  2. 2.
    Wiggins LF (1975) Curr Med Res Opin 3:241–248PubMedCrossRefGoogle Scholar
  3. 3.
    Aylward M, Maddock J, Wheeldon R, Parker RJ (1975) Rheumatol Rehabil 14:101–114PubMedCrossRefGoogle Scholar
  4. 4.
    Aylward M (1975) Curr Med Res Opin 3:249–263PubMedCrossRefGoogle Scholar
  5. 5.
    Hort JF (1975) Curr Med Res Opin 3:333–337PubMedCrossRefGoogle Scholar
  6. 6.
    Mercier M, Poncelet F, de Meester C, McGregor DB, Willins MJ, Leonard A (1983) J Appl Toxicol 3:230–236PubMedCrossRefGoogle Scholar

Hs/KA

  1. 1.
    Miller JA, Munro DD (1980) Drugs 19:119–134PubMedCrossRefGoogle Scholar
  2. 2.
    Goa KL (1988) Drugs 36 S5:51–61PubMedCrossRefGoogle Scholar
  3. 3.
    Pichl J, Schell H (1990) Z Hautkrankheiten 65:527–533Google Scholar
  4. 4.
    Tronnier H (1987) Ärztl Kosmetologie 17:458–482Google Scholar
  5. 5.
    Leiferman KM, Schroeter A, Kirschner MK, Speisberg TC (1983) J Invest Dermatol 81:355–360PubMedCrossRefGoogle Scholar
  6. 6.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10PubMedGoogle Scholar
  7. 7.
    Miesfeld RL (1990) Am Rev Respir Dis 141 S2:S11–17PubMedGoogle Scholar
  8. 8.
    Bowen DL, Fauci AS (1988) Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–897Google Scholar
  9. 9.
    Lavker RM, Schechter NM, Lazarus GS (1986) Br J Dermatol 115 S31:101–107PubMedCrossRefGoogle Scholar
  10. 10.
    Lutsky BN, Berkenkopf J, Fernandez X, Green MJ, Monahan M, Shue HJ, Tiberi RL (1980) Allergologie 3,4:199–203Google Scholar
  11. 11.
    Lutsky BN, Berkenkopf J, Fernandez X, Monahan M, Watnick AS (1979) Arzneim Forsch 29:992–998Google Scholar
  12. 12.
    Bagatell FK, Barkoff Jr., Cohen HJ, Lasser AE, McCormick GE, Rex IH (1983) Curr Ther Res 33:46–52Google Scholar
  13. 13.
    Duke EE, Maddin S, Aggerwal A (1983) Curr Ther Res 33:769–779Google Scholar
  14. 14.
    Kalivas J, Miller OF, Murrel TW, Tromovitch TA, Vanderploeg DC (1983) Curr Ther Res 33:408–414Google Scholar
  15. 15.
    Müller W, Neumann Y (1985) Therapiewoche 35:942– 948Google Scholar

GM

  1. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarkes Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar
  2. 2.
    Levy GC, Nelson L (1972) Carbon-13 NMR Spectroscopy, Wiley-Interscience, New YorkGoogle Scholar
  3. 3.
    Verpoorte R, Hylands PJ, Bisset NG (1977) Org Magn Res 9:567–571CrossRefGoogle Scholar

VF

  1. 1.
    Lee C, Katz RL (1980) Brit J Anaesth 52:173–188PubMedGoogle Scholar
  2. 2.
    Foldes FF (1971) Anaesthesist 20:6–19PubMedGoogle Scholar
  3. 3.
    Dalton DW, Tyers MB (1982) J Auton Pharmacol 2:261–266PubMedCrossRefGoogle Scholar
  4. 4.
    Leung E, Mitchelson F (1982) Eur J Pharmacol 80:1–9PubMedCrossRefGoogle Scholar
  5. 5.
    Nedoma J, Dorofeeva NA, Tucek S, Shelkovnikov SA, Danilov AF (1985) Naunyn Schmiedeberg’s Arch Pharmacol 329:176–181CrossRefGoogle Scholar
  6. 6.
    Meijer DKF, Weitering JG (1970) Eur J Pharmacol 10:283–289PubMedCrossRefGoogle Scholar
  7. 7.
    Duvaldestin P (1981) Clin Pharmacokinetics (Auckland) 6:61–82CrossRefGoogle Scholar
  8. 8.
    Miller RD (1982) Brit J Anaesth 54:161–167PubMedCrossRefGoogle Scholar
  9. 9.
    Duvaldestin P, Gibert C, Henzel D, Guy P, Desmonts JM(1979) Intens Care Med 5:111–114CrossRefGoogle Scholar
  10. 10.
    Meyer M (1987) Physioligsche und pharmakologische Grundlagen der Anästhesie, VEB Verlag Volk und Gesundkeit, Berlin, S. 168Google Scholar
  11. 11.
    Feldman SA (1979) Normal neuromuscular transmission. In: Churchill-Davidson HC (Hrsg.) A practice of anaesthesia, 4.Aufl., Lloyd-Luke, London, S. 806–828Google Scholar
  12. 12.
    Kenndy BR, Kelman GR (1970) Brit J Anaesth 42:625–630CrossRefGoogle Scholar
  13. 13.
    Cummings MF, Russel WJ, Frewin DB (1983) Brit J Anaesth 55:619–623PubMedCrossRefGoogle Scholar
  14. 14.
    Azar I (1984) Anesthesiology 61:173–187PubMedCrossRefGoogle Scholar
  15. 15.
    Richardson FJ, Agoston S (1984) Neurocuscular blokking agents and skeletal muscle relaxants. In: Meyler L (Hrsg.) Side effects of drugs, 10. Aufl., Elsevier Publishers BV, Amsterdam, S. 204–231Google Scholar
  16. 16.
    Miller RD (1981) Neuromuscular blocking agents. In: Smith NTy, Miller RD, Corbascio AN (Hrsg.) Drug interactions in Anaesthesia, Lea und Febiger Verlag, Philadelphia, S. 249–269Google Scholar
  17. 17.
    Pollard BJ, Jones RM (1983) Brit J Anaesth 55:1.127–1.131Google Scholar

GA

  1. 1.
    Maume G, Filali-Ansary A, Giannini E, Hathout Y, Fischbach M, Maume BF (1991) Biochem Biophys Res Comm 175:596–603PubMedCrossRefGoogle Scholar
  2. 2.
    Funder JW, Feldman D, Edelman IS (1973) Endocrinol 92:994–1.004CrossRefGoogle Scholar
  3. 3.
    Arriza JL, Weinberger G, Cerelli TM, Glaser BL, Handelin DE, Housman DE, Evans RM (1987) Science 237:268–275PubMedCrossRefGoogle Scholar
  4. 4.
    Monder C (1991) FASEB J 5:3.047–3.054Google Scholar
  5. 5.
    Oberleithner H, Weigt M, Westphale H-J, Wang W (1987) Proc Nat Acad Sci 84:1.464–1.468CrossRefGoogle Scholar
  6. 6.
    Schultz SG (1990) News in Physiol Sci 5:140Google Scholar
  7. 7.
    Drury PL, Besser GM (1989) Adrenal Cortex. Hall R, Besser GM (Hrsg.) In: Fundamentals of Clinical Endocrinology, 175Google Scholar
  8. 8.
    Born J, DeKloet ER, Wenz H, Kern W, Fehm HL (1991) Am J Physiol 260:E183–188PubMedGoogle Scholar
  9. 9.
    Kümmerle F, Lemmer E (1985) Die Nebennierenrinde. In: Endokrine Krankheiten, S. 42Google Scholar
  10. 10.
    Kümmerle F (1985) Klinische Pharmakologie, 4. Aufl., V 3.5.3Google Scholar

vB

  1. 1.
    Barton DHR, Hesse RH, Pechet MM, Rizzardo E (1973) J Am Chem Soc 95(8):2748–2749PubMedCrossRefGoogle Scholar
  2. 2.
    Harrison RG, Lythgoe B, Wright PW (1973) Tetrahedron Lett 37:3649–3652CrossRefGoogle Scholar
  3. 3.
    Fürst A, Labler L, Meier W, Pfoertner KH (1973) Helv Chim Acta 56:1708–1710PubMedCrossRefGoogle Scholar
  4. 4.
    Weissenberg M, Maoz A, Levy A, Wasserman RH (1988) Planta Med 54(1):63–65PubMedCrossRefGoogle Scholar
  5. 5.
    Flann BC, Lodge BA (1986) J Assoc Off Anal Chem 69(6):1026–1030, zit. nach CA 106:38562ePubMedGoogle Scholar
  6. 6.
    Vanhaelen-Fastre R, Vanhaelen M (1979) J Chromatogr 179(1):131–142CrossRefGoogle Scholar
  7. 7.
    Pushkina IP, Petrova EA, Bogoslavskii NA, Ulanova NA, Prokhorova LV, Kisel’nikova TA (1980) Khim-Farm Zh 14(10):111–112, zit. nach CA 94:71578wGoogle Scholar
  8. 8.
    Holick MF, Semmler EJ, Schnoes HK, De Luca HF (1973) Science 180:190–191PubMedCrossRefGoogle Scholar

KU

  1. 1.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW (1976) J Clin Invest 57:1.540–1.547CrossRefGoogle Scholar
  2. 2.
    Ogata E (1990) Bone Miner 9:229–232PubMedCrossRefGoogle Scholar
  3. 3.
    Seino Y, Tanaka H, Yamaoka K, Yabuuchi H (1987) Bone Miner 2:479–485PubMedGoogle Scholar
  4. 4.
    Kimura Y, Nakayama M, Kuriyama S, Watanabe S, Kawaguchi Y, Sakai O (1991) Clin Nephrol 35:72–77PubMedGoogle Scholar

bm

  1. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar
  2. 2.
    Sear JW et al. (1980) J Pharm Pharmacol 32:349–352PubMedCrossRefGoogle Scholar

QO

  1. 1.
    Mar 29, S. 1.114Google Scholar

vB

  1. 1.
    Andrews CJH, Robertson JA, Chapman JM (1985) lancet 2:671–672PubMedCrossRefGoogle Scholar
  2. 2.
    Baley PL, Pace NL, Stanley TH (1983) Anesthesiology 59:A316CrossRefGoogle Scholar
  3. 3.
    Bentley JB, Finley JH, Humphrey LR, Gandolfi AJ (1983) Anesth Analg 62:245–292Google Scholar
  4. 4.
    Black TE, Kay B, Healy TEJ (1984) Anaesthesia 39:546–548PubMedCrossRefGoogle Scholar
  5. 5.
    Bovill JG, Sebel PS, Blackburn CL, Heykants J (1982) Anesthesiology 57:439–443PubMedCrossRefGoogle Scholar
  6. 6.
    Bovill JG, Sebel PS, Blackburn CL, Oei-Lim V, Heykants JJ (1984) Anesthesiology 61:502–506PubMedCrossRefGoogle Scholar
  7. 7.
    Bovill JG, Sebel PS, Stanley TH (1984a) Anesthesiology 61:731–755PubMedCrossRefGoogle Scholar
  8. 8.
    Bovill JG, Warren PJ, Schuller JL, Van Wezel HB, Hoeneveld MH (1984b) Anesth Analg 63:1.081–1.086CrossRefGoogle Scholar
  9. 9.
    Bower S, Hull CJ (1982) Br J Anesth 54:871–877CrossRefGoogle Scholar
  10. 10.
    Camu F, Gepts E, Rucquoi M, Heykants J (1982) Anesth Analg 61:657–661PubMedCrossRefGoogle Scholar
  11. 11.
    Cartwright DP, Dann WL, Hutchinson A (1989) Eur J Anaesthesiol 6 (2):103–109PubMedGoogle Scholar
  12. 12.
    Cooper GM, O’Connor M, Mark J, Harvey J (1983) Br J Anaesth 55:179–182SGoogle Scholar
  13. 13.
    De Lange S, De Bruijin NP (1983) Br J Anaesth 55:183–189SGoogle Scholar
  14. 14.
    De Lange S, Stanley TH, Boscoe MJ (1981) Br J Anaesth 53:1.291CrossRefGoogle Scholar
  15. 15.
    Ferrier C, Marty J, Bouffard Y, Haberer JP, Lewon JC, Duvaldestin P (1985) Anesthesiology 62:480–484PubMedCrossRefGoogle Scholar
  16. 16.
    Fragen RJ, Booij LHDJ, Braak GJJ, Vree TB, Heykants J, Crul JF (1983) Br J Anaesth 55:1.077–1.081Google Scholar
  17. 17.
    Hansten PD, Horn Jr. (1989) Drug Interactions, 6. Aufl., Lea& Febiger, Philadelphia, London, 620 S.Google Scholar
  18. 18.
    Helmers H, Van Peer A, Woestenborghs R, Noorduin H, Heykants J (1984) Clin Pharmacol Ther 36:239–243PubMedCrossRefGoogle Scholar
  19. 19.
    Howie MB, McSweeney TD, Lingam RP, Maschke SP (1985) Anesth Analg 64:877–887PubMedCrossRefGoogle Scholar
  20. 20.
    Hug C, De Lange S, Burm AGL (1983) Anesth Analg 62:266Google Scholar
  21. 21.
    Hulland CJ, Jacobson L (1983) Br J Anaesth 55:173S– 178SGoogle Scholar
  22. 22.
    Jaffe RS, Coalson D (1989) Anesthesiology 70:151–153PubMedCrossRefGoogle Scholar
  23. 23.
    Kay B (1981) Anaesthesia 36:949–951PubMedCrossRefGoogle Scholar
  24. 24.
    Kay B, Stephenson DK (1980) Anaesthesia 35:1.197–1.201Google Scholar
  25. 25.
    Kramer M, Kling D, Walter P, v Bormann B, Hempelmann G (1983) Anaesthesist 32:265–271PubMedGoogle Scholar
  26. 26.
    Larijani GE, Goldberg ME (1987) Clin Pharm 6:275– 282PubMedGoogle Scholar
  27. 27.
    Mahla ME, White SE, Moneta MD (1988) Anesthesiology 69:593–595PubMedCrossRefGoogle Scholar
  28. 28.
    Mather LE (1983) Clin Pharmacokinet 8:422–446PubMedCrossRefGoogle Scholar
  29. 29.
    McDonnell TE, Bartkowski RR, Kahn C (1984) Anesthesiology 61:A284CrossRefGoogle Scholar
  30. 30.
    Meuldermans W, Van Peer A, Hendrickx J, Woestenborghs R, Lauwers W, Heykants J, Vanden Bussche G, Van Craeyvelt H, Van Der Aa P (1988) Anesthesiology 69:527–534PubMedCrossRefGoogle Scholar
  31. 31.
    Meuldermans WEG, Hurkmans RMA, Heykants JJP (1982) Arch Int Pharmacodyn 257:4–19PubMedGoogle Scholar
  32. 32.
    Nauta J, de Lange S, Koopman D, Spierdijk J, Van Kleef J, Stanley TH (1982) Anesth Analg 61:267– 272PubMedCrossRefGoogle Scholar
  33. 33.
    Patrick M, Eagar BM, Toft DF, Sebel PS (1984) Br J Anaesth 56:861PubMedCrossRefGoogle Scholar
  34. 34.
    Reitz JA (1986) Drug Intell Clin Pharm 20 (5):335–341PubMedGoogle Scholar
  35. 35.
    Scott JC, Ponganis KV, Stanski DR (1985) Anesthesiology 62:234–241PubMedCrossRefGoogle Scholar
  36. 36.
    Sebel PS, Bovill JG, Van Der Haven A (1982) Br J Anaesth 54:1.185–1.189Google Scholar
  37. 37.
    Shinn AF (1989) Evaluations of Drug Interactions, Macmillan Publishing Co, New YorkGoogle Scholar
  38. 38.
    Stack CG, Rogers P, Linter SPK (1988) Br J Anaesth 60:222–227PubMedCrossRefGoogle Scholar
  39. 39.
    USPDI (1988) Drug Information for the Health Care Professional, 8. Aufl., US Pharmacopeial Convention Inc., RockvilleGoogle Scholar
  40. 40.
    Van Leeuwen L, Deen L (1981) Anaesthesist 30:115– 117PubMedGoogle Scholar
  41. 41.
    White PF, Coe V, Shafer A, Man-Ling Sung (1986) Anesthesiology 64:99–106PubMedCrossRefGoogle Scholar
  42. 42.
    Yeadon M, Kitchen I (1988) Neuropharmacology 27(4):345–348PubMedCrossRefGoogle Scholar

KG

  1. 1.
    Janssens F, Torremans J, Jansen PAJ (1986) J Med Chem 29:2290–2297PubMedCrossRefGoogle Scholar
  2. 2.
    Van Daale PGH, De Bruyn MFL, Boey JM, Sanczuk S, Agten JTM, Janssen PAJ (1976) Arzneim Forsch 26:1521–1531Google Scholar
  3. 3.
    Kráčmar J, Kráčmarová J, Kroárová A, Stejskal Z (1988) Pharmazie 43:173–176PubMedGoogle Scholar

EK

  1. 1.
    Szelenyi I, Schickaneder H (1987) Ulkustherpaie. In: Kleeman A, Lindner E, Engel J (Hrsg.) Arzneimittel, Fortschritte 1972 bis 1985: VCH-Verlag, Weinberg New York, S. 959–987Google Scholar
  2. 2.
    Nail SL, White JL Hern SL (1976) J Pharm Sci 65:1.391–1.393Google Scholar
  3. 3.
    Berstad A (1982) Üben Antazida eine hemmende Wirkung auf Pepsin aus? In: Halter F (Hrsg.) Antazida, Urban & Schwarzenberg, München Wien Baltimore, S. 19–25Google Scholar
  4. 4.
    Clain JE, Malagelada HR, Chadwik VS (1977) Gastroenterology 73:556–559PubMedGoogle Scholar
  5. 5.
    Szelenyi I, Postius S (1985) Gastroenterology 88:1.605Google Scholar
  6. 6.
    DiJoseph JF, Borella LE, Nabimir G (1989) Gastroenterology 96:730–735PubMedGoogle Scholar
  7. 7.
    Halter F, Lam SK (1989) Action of antacids: more than bulk neutralisation? In: Garner A, Whittle BJr. (Hrsg.) Advances in drug therapy of gastrointestinal unlceration. John Wiley & Sons, Chichester New York Brisbane Toronto Singapore, S. 109–119Google Scholar
  8. 8.
    Kaehny WD, Hegg AP, Alfrey AC (1977) N Engl J Med 296:1.389–1.390CrossRefGoogle Scholar
  9. 9.
    Cam JM, Lack VA, Eastwood JB, De Wardener HE (1976) Cli Sci Mol Med 51:407–414Google Scholar
  10. 10.
    Berstad A, Werberg R (1986) Scand J Gastroentol (Suppl.) 125:32–39CrossRefGoogle Scholar
  11. 11.
    Herzog P, Holtermüller KH (1982) Scand J Gastroentol (Suppl.) 75:56–62Google Scholar
  12. 12.
    Herzog P (1983) Z Gastroenterol (Suppl.) 21:117–126PubMedGoogle Scholar
  13. 13.
    Werberg W, Berstad A, Lange O, Schulz T, Aubert E (1985) Scand J Gastroentol 20:1.041–1.045Google Scholar
  14. 14.
    Rydning A, Weberg R, Lange O, Berstad A (1986) Gastroenterology 91:56–61PubMedGoogle Scholar
  15. 15.
    Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W (1980) N Engl J Med 302:426–430PubMedCrossRefGoogle Scholar
  16. 16.
    Saco LS, Orlando RC, Levinson SL, Bozymski EM, Jones ID, Frakes JT (1982) Gastroenterology 82:1.369– 1.373Google Scholar
  17. 17.
    Nyren O, Adami HO, Bates S, Bergstöm R, Gustavsson S, Lööf L, Nyberg A (1986) N Engl J Med 314:339–343PubMedCrossRefGoogle Scholar
  18. 18.
    Wienbeck M, Erckenbrecht J, Strohmeyer G (1983) Z Gastroenterol (Suppl.) 21:111–116PubMedGoogle Scholar
  19. 19.
    Potyk D (1970) New Engl J Med 283:134PubMedCrossRefGoogle Scholar
  20. 20.
    Alfrey AC, Le Gendre GR, Kaehny WD (1976) N Engl J Med 294:184–188PubMedCrossRefGoogle Scholar
  21. 21.
    Gugler R, Musch E (1983) Z Gastroenterol (Suppl.) 21:127–133PubMedGoogle Scholar
  22. 22.
    Shader RI, Georgotas A, Greenblatt DJ, Harmatz JS, Allen DA (1978) Clin Pharmacol Ther 24:308–315PubMedGoogle Scholar
  23. 23.
    Rivera-Calimlin L, Dujoune CA, Morgan JO, Lasagna L, Biachine Jr. (1971) Europ J Clin Invest 1:313–318CrossRefGoogle Scholar
  24. 24.
    Dollinger HC, Holzberg E (1986) Med Klin 81:15–19Google Scholar
  25. 25.
    Forth W (1988) Z Gastroenterol (Suppl.) 26:20–26Google Scholar

Wb

  1. 1.
    Haug A, Larsen B (1962) Acta Chem Scand 16:1.908– 1.918Google Scholar
  2. 2.
    Haug A (1964) Rept No 30, Norwegian Institute Seaweed Research, Trondheim, NorwayGoogle Scholar
  3. 3.
    Penman A, Sanderson GR (1972) Carbohyd Res 25:273–282CrossRefGoogle Scholar

BK

  1. 1.
    Jakob RB, Robert JG (1958) U.S.Pat. 2837518 (Rhone-Poulenc); CA (1958) 52:16382Google Scholar
  2. 2.
    Bourquin IP, Schwarb G, Gamboni G, Fischer R, Ruesch L, Guldimann S, Theus V, Schenker E, Renz J (1958) Helv Chim Acta 41:1072–1108CrossRefGoogle Scholar
  3. 3.
    Wunder H (1972) Pharm Ztg 117 (40):1452–1455Google Scholar
  4. 4.
    Ebel S (1977) Handbuch der Arzneimittel-Analytik, Verlag Chemie, Weinheim, S. 299Google Scholar

MP

  1. 1.
    Mar 29, p 462Google Scholar
  2. 2.
    Johnson PC, Masters YF (1962) J Lab Clin Med 59:993–999PubMedGoogle Scholar
  3. 3.
    Sponheim S, Aune H, Gulliksen M, Morland J (1990) Pharmacol Toxicol 67:243–245PubMedCrossRefGoogle Scholar
  4. 4.
    Pfeifer S, Bornschein I, Franke P, Fischer C (1986) Pharmazie 41:111–113PubMedGoogle Scholar
  5. 5.
    Davies DR, Doughty A (1966) BrJAnaesth38:878–885CrossRefGoogle Scholar
  6. 6.
    Mann NP (1981) Arch Dis Children 56:481–482CrossRefGoogle Scholar
  7. 7.
    Valman HB (1981) Br Med J 283:422–423CrossRefGoogle Scholar
  8. 8.
    Moyes DG (1973) Br J Anaesth 45:1.163–1.164CrossRefGoogle Scholar
  9. 9.
    Loan WB, Cuthbert D (1985) Br Med J 290:1.548–1.549CrossRefGoogle Scholar

sw

  1. 1.
    Dibbern HW (1978), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor AulendorfGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 1046Google Scholar
  3. 3.
    Amarendra P, Mitra AK, Mukhopadhyay AK (1982) J Indian Chem Soc 59:660–662Google Scholar

MP

  1. 1.
    Laville CI, Margarit J (1982) Sem Hôp Paris 58:323– 331PubMedGoogle Scholar
  2. 2.
    Bierbaum HG (1983) Fortschr Med 101:662–664PubMedGoogle Scholar
  3. 3.
    Hoffmann H, Jacobi S (1984) Arzneim Forsch 34:1.714–1.715Google Scholar
  4. 4.
    Fachinformation des Bundesverbandes der Pharmazeutischen Industrie e.V.Google Scholar

hr

  1. 1.
    Mitteilung der Firma Schürholz, MünchenGoogle Scholar
  2. 2.
    Dibbern HW (Hrsg.) (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar

LD

  1. 1.
    Lukasiak J, Jamrogiewicz Z, Sznitowska, M (1987) Pharmazie 200:42Google Scholar
  2. 2.
    Zaidi ZR, Sena FJ, Basilio CP (1982) J Pharm Sci 71:997–999PubMedCrossRefGoogle Scholar

FB

  1. 1.
    Kempter G, Jumar A (1991) Organische Pflanzenschutz-und Schädlingsbekämpfungsmittel, 4. Aufl., DVW-Verlag,S.33Google Scholar
  2. 2.
    Ogiermann L, Silowieki A (1981) Chromatographie 14:459–161CrossRefGoogle Scholar

ms

  1. 1.
    Cavallito CJ, Baily JA (1944) J Am Chem Soc 66:1950CrossRefGoogle Scholar
  2. 2.
    Koch HP, Jäger W (1989) Dtsch Apoth Ztg 129:273–276Google Scholar
  3. 3.
    Miething H (1985) Dtsch Apoth Ztg 126:2049–2050Google Scholar

ms

  1. 1.
    Nadkarni MV, Jones JW (1950) J Am Pharm Assoc 39:297Google Scholar
  2. 2.
    Arai K,Tamura S, Kawai K, Nakajima S (1989) Chem Pharm Bull 37:3.117Google Scholar
  3. 3.
    Dibbern HW (Hrsg.) (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar
  4. 4.
    Stevenson GW (1961) Analyt Chem 33:1.376Google Scholar
  5. 5.
    Goenechea S (1966) Z Analyt Chem 218:416CrossRefGoogle Scholar
  6. 6.
    Avdovich HW, Neville GA (1969) Can J Pharm Sci 4: 51Google Scholar
  7. 7.
    Rücker G (1966) Arch Pharm (Weinheim) 299:688CrossRefGoogle Scholar
  8. 8.
    Asada S, Nishijo J (1978) Bull Chem Soc Jp 51:3.379Google Scholar
  9. 9.
    Okada J, Esaki T (1974) Chem Pharm Bull 22:1.580CrossRefGoogle Scholar
  10. 10.
    Bauer KH, Moll H (1967): Die organische Analyse unter besonderer Berücksichtigung der Arzneistoffe, 5. Aufl., In: Pohloudek-Fabini R, Beyrich T (Hrsg.), Akad. Verl-Ges., Leipzig erlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona, S. 349Google Scholar

Hg

  1. 1.
    Kaneniwa N, Hiura M, Funaki T (1985) Int J Pharm 26:157–164CrossRefGoogle Scholar
  2. 2.
    Harvey DJ, Glazener L, Johnson DB, Butler CM, Horning MG (1977) Drug Metab Dispos 5:527–546PubMedGoogle Scholar
  3. 3.
    Keding H, Schmidt G (1969) Arzneim Forsch 19:342– 347Google Scholar
  4. 4.
    Wellhöner HH (1990) Allgemeine und systematische Pharmakologie und Toxikologie, 5. Aufl., SpringerCrossRefGoogle Scholar
  5. 5.
    Gressel PD, Gallelli JF (1968) J Pharm Sci 57:335–338PubMedCrossRefGoogle Scholar
  6. 6.
    Rizzi A, Lang HRM (1985) J Chromatogr 331:33–45CrossRefGoogle Scholar
  7. 7.
    Matzko-Hollenbach K, Jira T, Mezey G (1987) Arch Pharm (Weinheim) 320:282–284CrossRefGoogle Scholar
  8. 8.
    Bergmann F, Frank A, Neimann Z (1979) J Chem Soc Perkin I:2795CrossRefGoogle Scholar
  9. 9.
    Schneckenburger J, Quade-Henkel M (1984) Dtsch Apoth Ztg 124:1167–1670Google Scholar
  10. 10.
    Chatten LG, Boyce M, Moskalyk RE, Pons BS, Madan DK (1981) Analyst (London) 106:365–368CrossRefGoogle Scholar

hh

  1. 1.
    Zöllner N, Gröbner W (1987) Purinstoffwechsel, Uri-kosurika, Urikostatika: Pharmakotherapie der Gicht. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und Spezielle Pharmakologie und Toxikologie, S. 362–367Google Scholar
  2. 2.
    Elion GB (1978) Allopurinol and other inhibitors of urate synthesis. In: Kelly WN, Weiner IM (Hrsg.) Uric Acid, Handbook of Exp. Pharmacol., Vol.51, Springer Verlag, Berlin Heidelberg New York, S. 485–514CrossRefGoogle Scholar
  3. 3.
    Rundles RW, Wyngaarden JB, Hitchings GH, Elion GB, Silberman HR (1963) Trans Ass Amer Physicians 76:126–140Google Scholar
  4. 4.
    Zöllner N, Gröbner W (1970) Europ J Clin Pharmacol 3:56–58CrossRefGoogle Scholar
  5. 5.
    Simmonds HA, Rising TJ, Codenhead A, Hatfield PJ, Jones A, Cameron JS (1973) Biochem. Pharmacol., 22, 2.553–2.563Google Scholar
  6. 6.
    Insel PA (1990) Analgesic-antipyretics and antiinflammatory agents; Drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s The Pharmacological Basis of Therapeutics, S. 674–681Google Scholar
  7. 7.
    Gröning R (1986) Dtsch Apoth Ztg 126:965–968Google Scholar
  8. 8.
    Sarig S (1987) Miner Electrolyte Metab 13:251–256PubMedGoogle Scholar
  9. 9.
    Hopf M (1980) Dtsch Apoth Ztg 120:411–413Google Scholar
  10. 10.
    Witten FR, Morgan JW, Forster JG, Glenn JF (1983) J Urol 130:938–942PubMedGoogle Scholar
  11. 11.
    Thomson WH (1985) Med Hypotheses 17:175–189PubMedCrossRefGoogle Scholar
  12. 12.
    Berman JD (1988) Rev Infect Dis 10:560–586PubMedCrossRefGoogle Scholar
  13. 13.
    Hearse DJ, Manning AS, Downey JM, Yellon DM (1986) Acta Physiol Scand Suppl. 548:65–78PubMedGoogle Scholar
  14. 14.
    Simpson PJ, Lucchesi BR (1987) J Lab Clin Med 110:13–30PubMedGoogle Scholar
  15. 15.
    Simpson PJ, Mickelson JK, Lucchesi BR (1987) Fed Proc 46:2.413–2.421Google Scholar
  16. 16.
    Eddy LJ, Stewart Jr., Jones HP, Engerson TD, McCord JM, Downey JM (1987) Am J Physiol 22:H709–711Google Scholar
  17. 17.
    Sanfey H, Sarr MG, Bulkley GB, Cameron JL (1986) Acta Physiol Scand Supp. 548:109–118Google Scholar
  18. 18.
    Drayer DE (1976) Clin Pharmacokinet 1:426–443PubMedCrossRefGoogle Scholar
  19. 19.
    Lupton GH, Odom RB (1979) J Am Acad Dermatol 1:365–374PubMedCrossRefGoogle Scholar
  20. 20.
    Chawla SK, Patel HD, Soterakis J, Lopresti PA, D’Angelo WA (1977) Arthritis Rheum 20:1.546–1.549CrossRefGoogle Scholar
  21. 21.
    Koren G (1989) Med Toxicol Adverse Drug Exp 4:59– 72PubMedCrossRefGoogle Scholar
  22. 22.
    Raymond JZ, Goldman HM (1988) Cutis 41:323–326PubMedGoogle Scholar
  23. 23.
    Lerman S, Megaw JM, Gardner K (1982) Am J Ophthalmol 94:141–146PubMedGoogle Scholar
  24. 24.
    Lerman S, Megaw JM, Fraunfelder FT (1984) Am J Ophthalmol 97:205–209PubMedGoogle Scholar
  25. 25.
    Clair WK, Chylack LT Jr., Cook EF (1989) Brit J Ophthalmol 73:173–176CrossRefGoogle Scholar
  26. 26.
    Hande KR, Noone RM, Stone WJ (1984) Am J Med 76:47–56PubMedCrossRefGoogle Scholar
  27. 27.
    McElnay JC, Smith GD, Helling DK (1982) Drug Intell Clin Pharm 16:533–542PubMedGoogle Scholar
  28. 28.
    Colin JN, Farinotti R, Fredj G, Tod M, Clavel JP, Vignon E, Dietlin F (1986) Europ J Clin Pharmacol 31:53– 58CrossRefGoogle Scholar

Oß/al

  1. 1.
    Centolella AP, Nelson JW, Koloff H (1943) J Am Chem Soc 65:2.091CrossRefGoogle Scholar
  2. 2.
    Graf E, Preuß R (1979) Gadamers Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte, Bd. I/2, 3. Aufl., Vandenhoeck und Ruprecht, Göttingen, S. 341.Google Scholar
  3. 3.
    Kuhnert-Brandstätter M, Bachleitner-Hofmann F (1971) Arch Pharm 304:580CrossRefGoogle Scholar
  4. 4.
    Yih TD, van Rossum JM (1977) Biochem Pharmacol 26:2.117Google Scholar
  5. 5.
    Siek TJ, Osiewicz RJ (1975) J Forensic Sci 20:18PubMedGoogle Scholar
  6. 6.
    Goenechea S (1966) Fresenius’ Z Anal Chem 218:416CrossRefGoogle Scholar
  7. 7.
    Chang BL, Nuessle NO, Haney Jr. WG (1975) J Pharm Sci 11:1.787Google Scholar
  8. 8.
    Doornbos DA, de Zeeuw RA (1969) Pharm Weekbl 104:233PubMedGoogle Scholar
  9. 9.
    Gill R, Stead AH, Moffat AC (1981) J Chromatogr 204:275PubMedCrossRefGoogle Scholar
  10. 10.
    Schütz C, Schütz H (1975) Dtsch Apoth Ztg 113:1.559Google Scholar
  11. 11.
    Schütz H, Pielmeyer A, Weiler G (1990) Aerztl Labor 36:113Google Scholar
  12. 12.
    Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308:413CrossRefGoogle Scholar

RE

  1. 1.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    Okada H, Sumi M, Ahara M, Ishihara M (1969) Nippon Naibunpi Gakkai Zashi 44:1.274–1.276, zit. nach CA 72:109429Google Scholar
  2. 2.
    Bergink EW, Loonen PBA, Klosterboer HK (1985) J Steroid Biochem 23:165–168PubMedCrossRefGoogle Scholar
  3. 3.
    Oettel M, Schubert K (1985) Steroidhormone. In: Markwardt F, Matthies H, Oelssner W (Hrsg.) Medizinische Pharmakologie, Thieme, Leipzig, S.720Google Scholar
  4. 4.
    Zeelen FJ (1990) Medicinal chemistry of steroids, Elsevier, Amsterdam Oxford New York Tokyo, p. 108Google Scholar
  5. 5.
    Lauritzen Ch, Lehmann WD (1969) Besonderheiten der Wirkungen der einzelnen Gestagene auf Morphologie und Funktion des Genitaltraktes, A. Beim Menschen. In: Junkmann K (Hrsg.) Die Gestagene, Teil 2, Handbuch der experimentellen Pharmakologie, Band XXII/2, Springer, Berlin Heidelberg New York, Kapitel IX, S. 13Google Scholar
  6. 6.
    Madjerek Z, Visser J de, Vies J van der, Overbeek GA (1960) Acta Endocr 35:8–19PubMedGoogle Scholar

OM

  1. 1.
    Patent Japan. Kokai 74 76,887 1974, zit. nach CA 85:63094jGoogle Scholar
  2. 2.
    Patent Can. 983,497(Cl.260–249.2) 1976, zit. nach CA 85:21479hGoogle Scholar
  3. 3.
    Patent Span. Es 542,481 (C1.C07D403/04) 1985, zit. nach CA 106:84654jGoogle Scholar
  4. 4.
    Luijten W (1989) J Chromatogr 474:265–273PubMedCrossRefGoogle Scholar
  5. 5.
    Patent Ger Offen l,947,332(Cl.C07d,A 61k) 1970, zit. nach CA 72:121586rGoogle Scholar
  6. 6.
    Baune A, Bromet N (1981) J Chromatogr 223:219–224PubMedGoogle Scholar
  7. 7.
    Parkhurst GW (1983) J Chromatogr 278:209–215PubMedGoogle Scholar
  8. 8.
    Kaiser F et al (1987) Analytical Letters 20(7):1051– 1067CrossRefGoogle Scholar

LD

  1. 1.
    McQueen DS, Evrard Y, Gordon BH, Campbell DB (1989) J Auton Nerv Syst 27:57–66PubMedCrossRefGoogle Scholar
  2. 2.
    Weitzenblum E, Apprill M, Oswald M, Kurzt D (1990) Lung 16B Suppl.:948–954CrossRefGoogle Scholar

hr

  1. 1.
    Mitteilung der Firma Itherapia, MünchenGoogle Scholar

LD

  1. 1.
    Auterhoff H, Graf E, Eurisch G, Alexa M (1980) Arch harm 313:113–120CrossRefGoogle Scholar
  2. 2.
    Stahl E, Schild W (1986) Isolierung und Charakterisierung von Naturstoffen, Gustav Fischer Verlag, Stuttgart New YorkGoogle Scholar
  3. 3.
    Rauwald HW(1984) Arch Pharm 317:362–367CrossRefGoogle Scholar
  4. 4.
    Graf E, Breitmaier E, Alexa M (1980) Planta Med 40: 197–201CrossRefGoogle Scholar
  5. 5.
    Rauwald HW(1982) Arch Pharm 315:769–772CrossRefGoogle Scholar
  6. 6.
    Grün M, Franz G (1979) Pharmazie 34:669–670Google Scholar
  7. 7.
    Graf E, Alexa M (1980) Planta Med 38:121–127CrossRefGoogle Scholar

  1. 1.
  2. 2.
    Capasso F, Mascolo N, Autore G, Duraccio MR (1983) Prostaglandins 26:557–562PubMedGoogle Scholar
  3. 3.
    Ammon HPT (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 380–384Google Scholar
  4. 4.
    Ehrhart G, Ruschig H (1968) Arzneimittel, Bd. III, Verlag Chemie GmbH, Weinheim, Bergstraße, S. 105Google Scholar
  5. 5.
    Paszkiewicz-Gadek A, Chlabicz J, Galasinski W (1988) Pol J Pharmacol Pharm 40:183–190PubMedGoogle Scholar
  6. 6.
    Goodman LS, Gilman A (1975) The pharmacological basis of therapeutics, 5. Aufl., MacMillan Publishing Company, New York Toronto London, S. 984Google Scholar
  7. 7.
    Mutschier E (1986) Arzneimittelwirkungen, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, S. 506Google Scholar
  8. 8.
    Hattori M, Kanda T, Shu YZ, Akao T, Kobashi K, Namba T (1988) Chem Pharm Bull 36:4.462–4.466Google Scholar
  9. 9.
    Heintz R (1978) Erkrankungen durch Arzneimittel, Georg Thieme Verlag, Stuttgart, S.303Google Scholar
  10. 10.
    Goodman LS, Gilman A (1966) The pharmacological basis of therapeutics, 3. Aufl., MacMillan Publishing Company, New York Toronto London, S. 1017Google Scholar

PK

  1. 1.
    Rauwald HW, Lohse K, Bats JW (1989) Angew Chem 101:1539–1540CrossRefGoogle Scholar
  2. 2.
    Auterhoff H, Graf E, Eurisch G, Alexa M (1980) Arch Pharm 313:113–120CrossRefGoogle Scholar
  3. 3.
    Grün M, Franz G (1979) Pharmazie 34:669–670Google Scholar
  4. 4.
    Rauwald HW (1982) Arch Pharm 315:769–772CrossRefGoogle Scholar
  5. 5.
    Graf E, Alexa M (1980) Planta Med 38:121–127CrossRefGoogle Scholar

  1. 1.
    Rauwald HW, Lohse K, Bats JW (1989) Angew Chem 101:1539–1540CrossRefGoogle Scholar
  2. 2.
    Auterhoff H, Graf E, Eurisch G, Alexa M (1980) Arch Pharm 313:113–120CrossRefGoogle Scholar
  3. 3.
    Rauwald HW (1982) Arch Pharm 315:769–772CrossRefGoogle Scholar
  4. 4.
    Graf E, Alexa M (1980) Planta Med 38:121–127CrossRefGoogle Scholar

  1. 1.
    Reynolds JEF (Hrsg.) (1989) Martindale, The Extra Pharmacopoeia, 29. Edition, The Pharmaceutical Press, LondonGoogle Scholar
  2. 2.
    Rowan RM, McDonald GA, Renton RL, Corne SJ, Brown DF (1976) Postgraduate Medical Journal 52:71–75PubMedCrossRefGoogle Scholar
  3. 3.
    Roberts SD, Chander VIR, Porter KG (1981) Eur J Rheum Inflam 4:323–331Google Scholar
  4. 4.
    Mitchell RA, Woolf D, Murray-Leslie C, Huskisson EC, Wojtulewsky J, Ansell B, Liyanage SP, Doyle D, Colston J, English Jr. (1987) Br J Clin Pract 41:560–565PubMedGoogle Scholar
  5. 5.
    Kanková D, Vojtisek O, Pavelka K, Hándlová D (1974) Int J Clin Pharmacol 10:56–63PubMedGoogle Scholar
  6. 6.
    Vojtisek O, Kanková D, Pavelka K, Hándlová D (1975) Arzneim Forsch 25:1.308–1.311Google Scholar
  7. 7.
    Wrighz MG (1976) J Int Med Res 4:272–275Google Scholar
  8. 8.
    Cummings AJ, Martin BK, Wiggins LE (1963) J Pharm Pharmacol 15:56–62PubMedCrossRefGoogle Scholar
  9. 9.
    Barraclough DRE, Muirden KD, Laby B (1975) Aust NZ J Med 5:518–523CrossRefGoogle Scholar
  10. 10.
    Wood PH, Harvey-Smith EA, Dixon AS (1962) Br Med J 1:669–675PubMedCrossRefGoogle Scholar
  11. 11.
    Rowan RM, McDonald GA, Renton RL, Corne SJ (1976) Clinical Trials Journal 13:60–67Google Scholar
  12. 12.
    Pavelka K, Vojtisek O, Kanková D (1980) Rheumatology and Rehabilitation 19:109–112PubMedCrossRefGoogle Scholar
  13. 13.
    Takavarasha L, Scott DL, Constable TJ (1982) Rheumatology and Rehabilitation 21:201–205PubMedCrossRefGoogle Scholar

Me

  1. 1.
    Sternbach LH (1978) Progr Drug Res 22:229–266Google Scholar
  2. 2.
    Hester BJ (1986) in Berger JG (Edit) Antianxiety Drugs 6:51–125 Wiley, New YorkGoogle Scholar
  3. 3.
    Ebel S (1977) Handbuch der Arzneimittel-Analylik.Verlag Chemie, WeinheimGoogle Scholar
  4. 4.
    Schütz H (1989) Benzodiazepines II, Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar

  1. 1.
    Hafely W, Kyburz E, Gerecke M, Möhler H (1985) Adv Drug Res 14:165–322Google Scholar
  2. 2.
    Dawson GW, Jue SG, Brogden RN (1984) Drugs 27:132–147PubMedCrossRefGoogle Scholar
  3. 3.
    Ballenger JC (1990) J Psychiat Res 24 (Suppl.2):15–25PubMedCrossRefGoogle Scholar
  4. 4.
    Laakmann G, Blaschke D, Hippius H, Messerer D (1986) Wirksamkeits-und Verträglichkeitsvergleich von Alprazolam gegen Amitriptylin bei der Behandlung von depressiven Patienten in der Praxis des niedergelassenen Allgemein-und Nervenarztes. In: Hippius H, Engel RR, Laakmann G (Hrsg.) Benzodiazepine, Rückblick und Ausblick, Springer, Heidelberg, S. 139–147CrossRefGoogle Scholar
  5. 5.
    Schweizer E, Fox I, Case G, Rickeis K (1988) Psychopharmacol Bull 24:224–227PubMedGoogle Scholar
  6. 6.
    Tiller J, Schweitzer I, Maguire K, Davies B (1989) Br J Psychiat 155:483–489CrossRefGoogle Scholar
  7. 7.
    Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI (1983) Clin Pharmacokin 8:233–252CrossRefGoogle Scholar
  8. 8.
    KlotzU(1984) Progr Clin Biochem Med Vol 1:117–167CrossRefGoogle Scholar

Wm

  1. 1.
    Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, Vol. 1, S. 47, Noyes PublicationGoogle Scholar
  2. 2.
    Brändström A, Corrodi A, Junggren U, Jönsson TE (1966) Acta Pharm Suec 3:303; CA (1968) 68:21.622PubMedGoogle Scholar
  3. 3.
    Jpn Kokai Tokkyo Koho (1982) JP 8267544; CA (1982) 97:162573Google Scholar

RE

  1. 1.
    Palm D, Hellenbrecht D, Quiring K (1988) Pharmakologie des noradrenergen und adrenergen Systems. Katecholamine, Adrenezeptor-Agonisten und -Anta-gonisten, Antisympathotonika und andere Anti-hypertensiva. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., Wissenschaftsverlag, S. 147Google Scholar
  2. 2.
    Leclerc G, Rouot B, Velly J, Schwartz J (1981) TIPS 2:18–20Google Scholar
  3. 3.
    Takayanagi I, Koike K, Sato T (1984) Jap J Pharmacol 35:301–305PubMedCrossRefGoogle Scholar
  4. 4.
    Mar 29, S. 782–783Google Scholar

PK

  1. 1.
    Brändström A, Corrodi H, Jungren U, Jönsson TE (1966) Acta Pharm Suec 3:303PubMedGoogle Scholar

RE

  1. 1.
    Brändström A, Corrodi H, Jungren U, Jönsson TE (1966) Acta Pharm Suec 3:303PubMedGoogle Scholar

RE

  1. 1.
    Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, Vol.1, S. 48, Noyes PublicationsGoogle Scholar
  2. 2.
    Ebel S (1977) Handbuch der Arzneimittelanalytik, Verlag Chemie, S. 346ffGoogle Scholar
  3. 3.
    Elks J, Ganellin C R (1990) Dictionary of Drugs, Chapman and Hall, London-New York-Tokio-Melbourne-Madras,S.34Google Scholar
  4. 4.
    Dibbern H-W (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Edition Cantor, AulendorfGoogle Scholar
  5. 5.
    Reimann E (1992) nicht publiziertGoogle Scholar

RE

  1. 1.
    Sih CJ et al (1973) J Am Chem Soc 95 (5): 1676–1677PubMedCrossRefGoogle Scholar
  2. 2.
    Wendler NL et al (1974) Tetrahedron 30:819–830CrossRefGoogle Scholar
  3. 3.
    Corey EJ, Noyori R, Schaaf TK (1970) J Am Chem Soc 92(8):2586–2587PubMedCrossRefGoogle Scholar
  4. 4.
    Kurozumi S et al, Noyori R et al (1987) Tetrahedron 43:813–824CrossRefGoogle Scholar
  5. 5.
    Miyano M, Stealey MA (1975) J Org Chem 40:1748– 1755PubMedCrossRefGoogle Scholar
  6. 6.
    Sih CJ et al (1972) J Am Chem Soc 94:3643–3644PubMedCrossRefGoogle Scholar
  7. 7.
    Wenkert E et al (1973) Tetrahedron Lett 7:515–518Google Scholar
  8. 8.
    Cepa SR et al (1984) Prostaglandins 27(4):645–652PubMedGoogle Scholar
  9. 9.
    Patent Eur.Pat.Appl.EP 310,409 (C1.D07C177/00) 1989, zit. nach CA 111:194447eGoogle Scholar
  10. 10.
    Novotny M et al (1984) J Chromatogr 292:159–167PubMedCrossRefGoogle Scholar
  11. 11.
    Krakauer KA et al (1986) Prostaglandins 32(2):301– 310PubMedGoogle Scholar
  12. 12.
    Yamamura K, Yamada J-I (1985) J Chromatogr 331:383–388PubMedCrossRefGoogle Scholar
  13. 13.
    Doehl J, Greibrook T (1983) J Chromatogr 282:435– 442CrossRefGoogle Scholar
  14. 14.
    Doehl J, Greibrook T (1985) J Chromatogr 349:431– 438CrossRefGoogle Scholar
  15. 15.
    Fitzpatrick FA et al (1977) Anal Chem 49(7):1032– 1035PubMedCrossRefGoogle Scholar
  16. 16.
    Patent Jpa. Kokai Tokkyo Koho JP 02,140,666 [90,140,666] (C1.G01N33/50) 1990, zit. nach CA 114: 225198tGoogle Scholar
  17. 17.
    Miyazaki M et al (1984) J Chromatogr 289:249–258PubMedCrossRefGoogle Scholar
  18. 18.
    Gleispach et al (1985) J Chromatogr 344:11–21PubMedGoogle Scholar
  19. 19.
    Jaffe BM et al (1971) Science 171:494PubMedCrossRefGoogle Scholar
  20. 20.
    Naderi S, Melchior DL (1990) Anal Chem 190:304–308Google Scholar
  21. 21.
    Yamamura K, Yotsuyanagi T (1984) J Chromatogr 303:165–172PubMedCrossRefGoogle Scholar
  22. 22.
    Youmger EW, Szabo RM (1986) Prostaglandins 31(5):923–927Google Scholar
  23. 1.
    Bergström S, Carlson LA, Weeks Jr. (1968) Pharmacol Rev 20:1–48PubMedGoogle Scholar
  24. 2.
    Strickland S, Beers WH (1976) J Biol Chem 251:5.694-5.702Google Scholar
  25. 3.
    Kinlough-Rathbone RL, Packham MA, Mustard JF (1970) Br J Haematol 19:559–571PubMedCrossRefGoogle Scholar
  26. 4.
    Sinzinger H (1986) Inhibition of mitotic and proliferative activity of smooth muscle cells by Prostaglandin E1. In: Sinzinger H, Rogatti W (Hrsg.) Prostaglandin E1 in Atherosclerosis, Springer, Berlin Heidelberg, S. 39–48CrossRefGoogle Scholar
  27. 5.
    Sinzinger H, Virgolini I, Fitscha P (1989) VASA (Suppl28):6–13Google Scholar
  28. 6.
    Hamberg M, Samuelsson B (1971) J Biol Chem 241:6.713–6.721Google Scholar
  29. 7.
    Simmet P, Peskar BA, Wolf HRD (1986) On the metabolism of prostaglandin E1 in patients suffering from arterial occlusive disease. In: Sinzinger H, Rogatti W (Hrsg.) Prostaglandin E1 in Artherosclerosis, Springer, Berlin Heidelberg, S.8–12CrossRefGoogle Scholar
  30. 8.
    Gruß JD, Vargas-Montano H, Bartels D, Simmenroth HW, Sakurai T, Schäfer G, Fietze-Fischer B (1984) Int Angio(Suppl3):7–17Google Scholar
  31. 9.
    Balzer K, Rogatti W, Rüttgerodt K (1989) Therapiewoche 39:2.736–2.742Google Scholar
  32. 10.
    Heidrich H, Ranft J, Peters A, Rummel S (1987) VASA (Suppl 20):202–203Google Scholar
  33. 11.
    Trübestein G, Ludwig M, Diehm C, Gruß JD, Horsch S (1987) Dtsch Med Wschr 112:955–959PubMedCrossRefGoogle Scholar

Wb

  1. 1.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin, Nr. 6.209Google Scholar

vB

  1. 1.
    Kaiser DW, Thurston JT, Dudley Jr., Schaefer FC, He-chenbleikner I, Holm-Hansen D (1951) J Am Chem Soc 73:2.984–2.986CrossRefGoogle Scholar
  2. 2.
    Drugs of Today (1982) 18:164–167Google Scholar
  3. 3.
    Dibbern HW (Hrsg.) (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf Nr. 982.Google Scholar

AE

  1. 2.
    Rutty CJ, Connors TA (1977) Biochem Pharmacol 26:2385–2391PubMedCrossRefGoogle Scholar
  2. 3.
    Rutty CJ, Connors TA, Hoang-Nam N et al. (1978) Eur J Cancer 14:713–720PubMedGoogle Scholar
  3. 4.
    D’Incalci M, Bolis G, Mangioni C et al. (1978) Cancer Treat Rep 62:2117–2119PubMedGoogle Scholar
  4. 5.
    Ames MM, Powis G, Kovach JS et al. (1979) Cancer Res 39:5016–5021PubMedGoogle Scholar
  5. 6.
    Bryan GT, Worzalla JF, Gorske AL et al. (1968) Clin Pharmacol Ther 9:777–782PubMedGoogle Scholar
  6. 7.
    D’Incalci M, Beggiolin G, Sessa C et al. (1981) Eur J Clin Oncol 17:1331–1335CrossRefGoogle Scholar
  7. 8.
    Foster BJ, Harding BJ, Leyland-Jones B et al. (1986) Cancer Treat Rev 13:197–217PubMedCrossRefGoogle Scholar
  8. 9.
    Broggini M, Colombo T, D’Incalci M et al. (1981) Cancer Treat Rep 65:669–672PubMedGoogle Scholar
  9. 10.
    D’Incalci M, Farina P, Sessa C et al. (1982) Cancer Treat Rep 66:231–235PubMedGoogle Scholar
  10. 11.
    Wharton JT, Rutledge F, Smith JP et al. (1979) Am J Obstet Gynecol 133:833–844PubMedGoogle Scholar
  11. 12.
    Hainsworth JD, Grosh WW, Burnett LS et al. (1988) Ann Intern Med 108:165–170PubMedCrossRefGoogle Scholar
  12. 13.
    Ihde DC, Dutcher JS, Young RC et al. (1981) Cancer Treat Rep 65:755–762PubMedGoogle Scholar

OJ

  1. 1.
    Worzalla JF, Johnson BM, Ramirez G et al. (1973) Cancer Res 33:2810–2815PubMedGoogle Scholar
  2. 1.
    Febvre P, Bex JF, Thivend P, Aiache JM (1970) CRSoc Biol 164:121–124Google Scholar
  3. 2.
    Gadalla MA, Ismail AA, Abd El-Hameed MH (1989) Drug Dev Ind Pharrn 15:447–472CrossRefGoogle Scholar
  4. 3.
    Kaniwa N, Ogata H, Aoyagi N, Ejima A (1981) J Phar-macobio-Dyn 4:860–864CrossRefGoogle Scholar
  5. 4.
    Gorsky JE, Dietz AA, Spencer H, Osis D (1979) Clin Chem 25:1.739–1.743Google Scholar
  6. 5.
    Greger JL, Baier MJ (1983) Fd Chem Tox 21:473–476CrossRefGoogle Scholar
  7. 6.
    Alfrey AC (1983) Adv Clin Chem 23:69–91PubMedCrossRefGoogle Scholar
  8. 7.
    Henning HV (1989) Klin Wochenschr 67:1.221–1.228CrossRefGoogle Scholar
  9. 8.
    Alfrey AC (1986) Kid Intern 29, Suppl 18:8–11Google Scholar

Me

  1. 1.
    BAz, Nr. 190a vom 10.10.1985Google Scholar

GS

  1. 1.
    l.Mar 29, S.777Google Scholar

vB

  1. 1.
    Mar 29, S.777Google Scholar

vB

  1. 1.
    Mar 29, S. 777Google Scholar

vB

  1. 1.
    GB 860.303 (1961), CA (1961) 55:24680Google Scholar
  2. 2.
    CS 176.806 (1979), CA (1979) 90:203701Google Scholar
  3. 3.
    DOT (1970) 6:6–8Google Scholar

NP/Ba

  1. 1.
    Cayen MN (1985) Pharmacol Ther 29:157–204PubMedCrossRefGoogle Scholar
  2. 2.
    Mannisto PT, Tuomistr J, Jounela A, Penttila O (1975) Acta Pharm Toxic 36:353–365CrossRefGoogle Scholar
  3. 3.
    Harvengt C, Desager JP (1977) Int J Pharmacol Bio-pharm 15:1–4Google Scholar

Bj

  1. 1.
    Mar 28, S. 284Google Scholar

vB

  1. 1.
    Krantz JC, Kibler DV, Bell FK (1944) J Pharmacol Exp Ther 82:247–253Google Scholar

Gm

  1. 1.
    Forth W, Henschler D, Rummel W (1987) Pharmakologie und Toxikologie, 5. Aufl. Wissenschaftsverlag, Mannheim Wien Zürich, S. 335–338Google Scholar
  2. 2.
    Füllgraff G, Palm D (1989) Pharmakotherapie, Klinische Pharmakologie, 7. Aufl., Gustav Fischer Verlag, Stuttgart New York, S. 157Google Scholar
  3. 3.
    Schulz W, Deuber HJ (1988) Fortschr Med 106:260– 263PubMedGoogle Scholar
  4. 4.
    Grossman MI (1981) Regulation of gastric acid secretion. In: Johnson LR (Hrsg.) Physiology of the gastrointestinal tract, Raven Press, New YorkGoogle Scholar
  5. 5.
    Piper DW (1988) Clin Gastroenterol Tindall, London Philadelphia Sydney Tokyo TorontoGoogle Scholar
  6. 6.
    Carlson GL, Malagelada Jr. (1982) Chemistry of antacids, Urban und Schwarzenberg, MünchenGoogle Scholar

bh

  1. 1.
    Helmboldt O (1985) Aluminum Compounds, Inorganic. In: Gerhartz W (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl, Bd A1, VCH Verlagsgesellschaft, Weinheim, S.532Google Scholar
  2. 2.
    Gmelin’s Handbuch der Anorganischen Chemie (1934) Aluminium, System Nr.35B, 8. Aufl, Verlag Chemie, Weinheim, S. 458–63Google Scholar
  3. 3.
    DAB 10, V3.5.4Google Scholar

WS

  1. 1.
    Mar 29, S. 1.074Google Scholar

vB

  1. 1.
    Haas H, Phosphoroxide, Phosphorsäuren und Phosphate. In: Ull; Band 18:335Google Scholar
  2. 2.
    Gmelin’s Handbuch der Anorganischen Chemie (1933) Aluminium, System Nr.35B, 8. Aufl., Verlag Chemie, Weinheim, S.345Google Scholar

ws/Eb/fb

  1. 1.
    Helmboldt O (1985) Aluminum Compounds, Inorganic. In: Gerhartz W (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl, Bd A1, VCH Verlagsgesellschaft, Weinheim, S. 527 ffGoogle Scholar
  2. 2.
    DAB 10,V.3.5.4Google Scholar

ws

  1. 1.
    Mar 29, S. 778Google Scholar
  2. 2.
    Gloor M (1982) Pharmakologie dermatologischer Externa, Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  3. 3.
    Hölzle E, Kligman AM (1979) J Soc Cosm Chem 30:357–367Google Scholar
  4. 4.
    Quatrale RP, Waldman AH, Rogers JG, Felger CB (1981) J Soc Cosm Chem 32:67–73Google Scholar
  5. 5.
    McLoed LJ, Witt von RJ, Roberts MSS (1986) Med J Aust 144:220–221Google Scholar

Gs

  1. 1.
    Külz F, et al (1939) Ber Dtsch Chem Ges 72:2161CrossRefGoogle Scholar
  2. 2.
    Stühner W, Elbrächter EA (1954) Arch Pharm 287:139CrossRefGoogle Scholar
  3. 3.
    Clarke EGC (1969) Isolation and Identification of Drugs, S. 182, Pharmaceutical Press, LondonGoogle Scholar
  4. 4.
    Eckert T (1955) Dtsch Apoth Ztg 95:646–647Google Scholar
  5. 5.
    Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr 323:191–225PubMedCrossRefGoogle Scholar

Sf

  1. 1.
    Mar 29, Alverine citrate, S. 1.541Google Scholar

EH

  1. 1.
    Stetter H, Schwarz M, Hirschhorn A (1959) Chem Ber 92:1.629–1.635Google Scholar
  2. 1a.
    Stetter H, Mayer J, Schwarz M, Wulff K (1960) Chem Ber 93:226–230CrossRefGoogle Scholar
  3. 2.
    Craven SM (1973) Spectrochimica Acta 29A:679–685Google Scholar
  4. 3.
    Fort RC Jr., von Schleyer PR (1965) J Org Chem 30:789–796CrossRefGoogle Scholar
  5. 4.
    Duddeck H, Wolff P (1976) Org Magn resonance 8:593–600CrossRefGoogle Scholar
  6. 5.
    Perrin DD, Hawkins I (1972) Experientia 28:880CrossRefGoogle Scholar
  7. 6.
    Bewick A, Edwards GJ, Stephen RJ, Mellor JM (1977) J Chem Soc, Perkin Trans 1:1.831–1.834Google Scholar
  8. 7.
    Daldrup T, Susanto F, Michalke P (1981) Fresenius Z Anal Chem 308:413–427CrossRefGoogle Scholar
  9. 8.
    Gupta RC, Lundberg GD (1977) Clin Toxicol 11:437–442PubMedCrossRefGoogle Scholar

EG

  1. 1.
    Douglas RG Jr. (1990) Antimicrobial agents. In: Gil-man AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s the pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S. 1182–1201Google Scholar
  2. 2.
    Dolin R, Reichmann RC, Madore HP et al. (1982) N Engl J Med 307:580–584PubMedCrossRefGoogle Scholar
  3. 3.
    Schwab RS, England AC, Poskanzer DC, Young RR (1969) J Amer Med Ass 208:1168–1170CrossRefGoogle Scholar
  4. 4.
    Quinn NP (1984) Drugs 28:236–262PubMedCrossRefGoogle Scholar
  5. 5.
    Cedarbaum JM (1987) Clin Pharmacokin 13:141–178CrossRefGoogle Scholar
  6. 6.
    Cedarbaum JM, Schleifer LS (1990) Drugs for Parkinson’s disease, spasticity, and acute muscle spasm. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s the pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S.463–468Google Scholar
  7. 7.
    Huber M (1987) Dtsch Med Wschr 113:992–998CrossRefGoogle Scholar
  8. 8.
    Parkes JD (1981) Drugs 21:341–353PubMedCrossRefGoogle Scholar

NB

  1. 1.
    Pehk T, Lippmaa E, Sevostjanova W, Krayuschkin MM, Tarasova AI (1971) Organic Magn Resonance 3:783–790CrossRefGoogle Scholar

EG

  1. 1.
    Köchel D, Messerschmidt W, Ruckriegel O, Scherbel G, Theuer H (1988), Pharm Ztg 133:82–86Google Scholar
  2. 2.
    DAC 1986,1. Ergänzung 1989, A-065,1–5Google Scholar

EG

  1. 1.
    Wunderer H (1986) Dtsch Apoth Ztg 126:2.281–2.292Google Scholar
  2. 2.
    Amlacher R, Baumgart J, Härte A, Weber H, Kühnel HJ, Schulze W, Hoffmann H (1990) Arch Geschwulstforsch 60:11–18PubMedGoogle Scholar

ak

  1. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London.Google Scholar

VF

  1. 1.
    Karczmar AG(1957) J Pharmacol Exp Ther 119:39–47PubMedGoogle Scholar
  2. 2.
    Lands AM, Karczmar AG, Arnold A (1957) J Pharmacol Exp Ther 119:541–549PubMedGoogle Scholar
  3. 3.
    Lands A, Karczmar AG, Howard JW, Arnold A (1955) J Pharmacol Exp Ther 115:185–198PubMedGoogle Scholar
  4. 4.
    Brown JH, Wetzel GT, Dunlap J (1982) J Pharmacol Exp Ther 223:20–24PubMedGoogle Scholar
  5. 5.
    Kenakin TP, Beek D (1985) J Pharmacol Exp Ther 232:732–740PubMedGoogle Scholar
  6. 6.
    Koelle GB (1962) J Pharm (London) 14:65–90CrossRefGoogle Scholar
  7. 7.
    Koster RR (1946) J Pharmacol Exp Ther 88:39–46PubMedGoogle Scholar
  8. 8.
    Schwab R (1955) Dtsch med Wochenschr 80:1.641–1.645CrossRefGoogle Scholar
  9. 9.
    Tharasse-Bloch C, Chabenat C, Boucly R, Marchand J (1987) J Chromatogr 421:407–411PubMedGoogle Scholar
  10. 10.
    Yamamoto K, Kohda Y, Saitoh Y, Nakayawa F (1988) J Chromatogr 433:167–176PubMedGoogle Scholar

GA

  1. 1.
    Dibbern HW, UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, AulendorfGoogle Scholar

SH

  1. 1.
    Püschmann S, Engelhorn R (1978) Arzneim Forsch/Drug Res 28:889–898Google Scholar
  2. 2.
    Iravani J, Melville GN (1974) Respiration 31:350–357PubMedCrossRefGoogle Scholar
  3. 3.
    Disse BG (1987) Eur J Respir Dis 71 (Suppl 153):255–262Google Scholar
  4. 4.
    Aliperta A, Bellissim O, Turco D, Antinolfi G (1986) Int J Tiss Reac 8:167–174Google Scholar
  5. 5.
    Cunningham FM, Morley J, Sanjar S (1982) Br J Pharmacol 80:694PGoogle Scholar
  6. 6.
    Weiss Th, Dorow P, Felix R (1981) Prax Pneumol 35:359–362Google Scholar
  7. 7.
    Matthys H, Vastag E, Daikeler G, Köhler D (1984) Die mukoziliäre Clearance des Bronchialbaums unter Me-thylxanthinen, Betamimetika und Sekretolytika. In: Nolte D, Krejci G (Hrsg.) Methylxanthine bei obstruktiven Atemwegserkrankungen, Dusti, München Dei-senhofen,S. 111–121Google Scholar
  8. 8.
    Prevost MC, Soula G, Doste-Blazy L (1979) Respiration 37:215–219PubMedCrossRefGoogle Scholar
  9. 9.
    Wauer RR, Schalisch G, Menzel K, Schroder M, Muller K, Tiller R (1982) Int J Biol Res Pregn 3:84–91Google Scholar
  10. 10.
    Stepinska J, Zbislawska P, Skoczowska W, Cretti A (1989) Zentralbl Gynekol 111:379–384Google Scholar
  11. 11.
    Szelenyi I, Engler H (1986) Pharmacology 33:199–205PubMedCrossRefGoogle Scholar
  12. 12.
    Stockley RA, Shaw J, Burnett D (1988) Agents Actions 24:292–296PubMedCrossRefGoogle Scholar
  13. 13.
    Becher G, Winsel K, Barleber A (1989) Biomed Bio-chim Acta 48:589–592Google Scholar
  14. 14.
    Wiemeyer JCM (1981) Arzneim Forsch/Drug Res 31:974–976Google Scholar
  15. 15.
    Hammer R, Bozler G, Jauch R, Koss FW (1978) Arzneim Forsch/Drug Res 28:899–903Google Scholar
  16. 16.
    Vergin H, Bishop-Freudling GB, Miczka M, Nitsche V, Strobel K, Matzkies F (1985) Arzneim Forsch/Drug Res 35:1591–1595Google Scholar
  17. 17.
    Loos U, Labedzki L, Weiss JM (1987) Prax Klin Pneumol 41:868–869Google Scholar
  18. 18.
    Ericsson CH, Juhasz J, Jönsson E, Mossberg B (1986) Eur J Respir Dis 69:248–255PubMedGoogle Scholar
  19. 19.
    Cegla UH (1988) Prax Klin Pneumol 42:715–721PubMedGoogle Scholar
  20. 20.
    Olivieri D, Zavattini G, Tomasini G et al. (1987) Respiration 51 (Suppl 1):42–51PubMedCrossRefGoogle Scholar
  21. 21.
    Ericsson CH, Juhasz J, Jönssen E, Mossberg B (1987) Respiration 51 (Suppl 1):33–36PubMedCrossRefGoogle Scholar
  22. 22.
    Germouty J, Jirou-Najou JL (1987) Respiration 51 (Suppl 1):37–41PubMedCrossRefGoogle Scholar
  23. 23.
    Schöpp W (1981) J Allg Med 57:1778–1785Google Scholar
  24. 24.
    Cosmi EV, Scarpelli EM (Eds.) (1983) Pulmonary Surfactant System, Elsevier, AmsterdamGoogle Scholar

SZ

  1. 1.
    Dibbern HW, UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, AulendorfGoogle Scholar
  2. 2.
    Püschmann S, Engelhorn R (1978), Arzneim Forsch 28:889Google Scholar

SH

  1. 1.
    Janssen PAJ (1954) J Am Chem Soc 76:6192–6193CrossRefGoogle Scholar
  2. 2.
    Janssen GmbH Neuss, Persönliche MitteilungGoogle Scholar
  3. 3.
    Clarke EGC (1969) Isolation and Identification of Drugs: 1002–1003, Pharmaceutical Press, LondonGoogle Scholar

Sf

  1. 1.
    Hoeckstra JB, Fischer DS, Tisch DE, Dickison HL (1957) J Pharmacol Exp Ther 119:153Google Scholar
  2. 2.
    De Jong DK, Janssen P, Proosdij-Hartzema EG (1954) Acta Physiol Pharmacol Neerl 3:331–335Google Scholar
  3. 3.
    Höckstra JB, Fischer DS, Cull KM, Tisch DE, Dickison HL (1957) J Am Pharm Assoc 46:564–568Google Scholar
  4. 4.
    Engelhorn R, Schmidt L (1956) Arzneim Forsch 6:434–436Google Scholar
  5. 5.
    Göbelsmann U, Beller FK (1961) Arzneim Forsch 11:929–932Google Scholar
  6. 6.
    Carpentier PJ, Janssen PA (1955) Lancet 1:122–125CrossRefGoogle Scholar

KC

  1. 1.
    Cheney LC, Wheatly WB, Speeter ME (1952) J Org Chem 17:770–777CrossRefGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, LondonGoogle Scholar

VF

  1. 1.
    De Jong DK, Van Proosdij-Hartzema EG, Janssen P (1955) Arch Int Pharmacodyn Ther 103:100–119Google Scholar
  2. 2.
    Southgate PJ (1972) Arch Int Pharmacodyn Ther 196:376–382PubMedGoogle Scholar
  3. 3.
    Judge RD, Bolt RJ, Hirschowitz BI, Pollard HM (1956) J Lab Clin Med 47:950–959PubMedGoogle Scholar
  4. 4.
    Hoeckstra JB, Dickinson HL (1958) J Pharmacol Exp Ther 98:14–21Google Scholar
  5. 5.
    Schwartz R, Lehmann E, Seibel JM (1960) Am J Gastroenterol 33:704–717PubMedGoogle Scholar
  6. 6.
    Martin W, Müller-Wieland K (1970) Z Gastroenterol 8:288–290Google Scholar
  7. 7.
    Cheney LC (1952) J Org Chem 17:770–777CrossRefGoogle Scholar
  8. 8.
    Ohlenschläger G, Schmidt KH (1974) Therapie der Gegenwart 2:234–252Google Scholar

KC

  1. 1.
    Miller JA, Munro DD (1980) Drugs 19:119–134PubMedCrossRefGoogle Scholar
  2. 2.
    Goa KL (1988) Drugs 36 S5:51–61PubMedCrossRefGoogle Scholar
  3. 3.
    Pichl J, Schell H (1990) Z Hautkrankheiten 65:527– 533Google Scholar
  4. 4.
    Tronnier H (1987) Ärztl Kosmetologie 17:458–482Google Scholar
  5. 5.
    Leiferman KM, Schroeter A, Kirschner MK, Spelsberg TC (1983) J Invest Dermatol 81:355–360PubMedCrossRefGoogle Scholar
  6. 6.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10Google Scholar
  7. 7.
    Miesfeld RL (1990) Am Rev Respir Dis 141 S2:S11–17PubMedGoogle Scholar
  8. 8.
    Bowen DL, Fauci AS (1988) Adrenal Corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R (Hrsg.)Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–897Google Scholar
  9. 9.
    Niedner R (1989) Dtsch Aerztebl 86:1798–1803Google Scholar
  10. 10.
    Cornell RC, Ellis CN (1989) Curr Ther Res 46:577Google Scholar
  11. 11.
    Solomon AR, Guenther L, Voorhees JJ (1981) Curr Ther Res 30:561–565Google Scholar
  12. 12.
    Ellis CN, Menter MA (1989) Curr Ther Res 46:471– 477Google Scholar
  13. 13.
    Hopf G, Mathias B (1989) Muench Med Wochenschr 131:595–599Google Scholar
  14. 14.
    Karl HJ (1980) Muench Med Wochenschr 122:1191– 1194Google Scholar
  15. 15.
    Takeda K, Arase S,Takahashi S (1988) Drugs 36:15–23PubMedCrossRefGoogle Scholar

GM

  1. 1.
    Reichender F et al (1981) Arzneim Forsch 31(11):1529–1638Google Scholar
  2. 2.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar
  3. 3.
    Mitteilung der Firma Nordmark, UetersenGoogle Scholar
  4. 4.
    Patent Ger Offen 1,912,941 (Cl.C07d,A01n) 1970, zit. nach CA 74:52822dGoogle Scholar

LD

  1. 1.
    Aust PE, Belz GG, Appel E, Palm D (1980) Z Kardiol 69:716Google Scholar
  2. 2.
    Gries J, Schuster J, Giertz H, Lehmann D, Lenke D, Worstmann W (1981) Arzneim Forsch 31:1.533–1.543Google Scholar
  3. 3.
    Schaps D, Seitz W, Hetzer R, Tholen A, Goroll D (1985) Anaesthesist 34:79–84PubMedGoogle Scholar
  4. 4.
    Lehman HD, Giertz H, Kretzschmar R, Lenke D, Phillipsborn Gv, Raschack M, Schuster J (1981) Arzneim Forsch 31:1.544–1.557Google Scholar
  5. 5.
    Lenke D, Gries J, Kretzschmar R (1981) Arzneim Forsch 31:1.558–1.565Google Scholar
  6. 6.
    Traut M, Brode E (1981) Arzneim Forsch 31:1.605–1.615Google Scholar
  7. 7.
    Traut M, Brode E, Wilsmann K (1981) Z Kardiol 70:292Google Scholar
  8. 8.
    Hengstmann JH (1976) Arzneim Forsch 26:1.251–1.252Google Scholar
  9. 9.
    Hengstmann JH, Goronzy J (1980) Arneim Forsch 30:2.164–2.167Google Scholar
  10. 10.
    Hengstmann JH, Weyand U, Dengler HJ (1975) Eu-rop J Clin Pharmacol 9:179–187CrossRefGoogle Scholar
  11. 11.
    Kaumeier HS, Kehrhahn OH, Morgenthaler H, Neu-gebauerG (1981) Arzneim Forsch 31:1.653–1.657Google Scholar
  12. 12.
    Traut M, Kummer H, Brode E (1981) Arzneim Forsch 31:1.616–1.622Google Scholar
  13. 13.
    Belz GG, Aust PE, Belz G (1981) Z Kardiol 70:706– 712PubMedGoogle Scholar
  14. 14.
    Bückert C (1981) Firtschr d Med 99:1.202–1.206Google Scholar
  15. 15.
    Jansen W (1981) Med Welt 32:1.491–1.496Google Scholar
  16. 16.
    Müller G (1981) Klinikarzt 10:1.316–s1.322Google Scholar
  17. 17.
    Editorial (1990) Der Arzneimittelbrief Jahrgang24, 1:1–2Google Scholar

Mt

  1. 1.
    Hyde JF, Browning E, Adams R (1928) J Am Chem Soc 50:2287–2292CrossRefGoogle Scholar
  2. 2.
    Schütte J (1961) USP 3001910 (Temmler Werke ert. 26.9.1961; Appl. 16.4.1958), zit. nach CA (1962) 56:2384gGoogle Scholar
  3. 3.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar
  4. 4.
    Alm S, Bomgren B, Boren HB, Karlsson H, Maehly AC (1982) Forensic Sci Int 19(3):271–280PubMedCrossRef